{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 510,
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "\n",
    "# rate limiting is important to avoid accidental service abuse of the OpenFDA API provider\n",
    "from ratelimit import limits, sleep_and_retry\n",
    "\n",
    "# cache API calls in a sqllite file to reduce the number of requests to openfda server\n",
    "import requests_cache\n",
    "requests_cache.install_cache('openfda_cache')\n",
    "\n",
    "OPENFDA_API = \"https://api.fda.gov/drug/event.json\"\n",
    "\n",
    "@sleep_and_retry\n",
    "@limits(calls=40, period=60)\n",
    "def call_api(params):\n",
    "    \"\"\"\n",
    "    OpenFDA API call. Respects rate limit. Overrides default data limit\n",
    "    Input: dictionary with API parameters {search: '...', count: '...'}\n",
    "    Output: nested dictionary representation of the JSON results section\n",
    "    \n",
    "    OpenFDA API rate limits:\n",
    "         With no API key: 40 requests per minute, per IP address. 1000 requests per day, per IP address.\n",
    "         With an API key: 240 requests per minute, per key. 120000 requests per day, per key.\n",
    "    \"\"\"\n",
    "    if not params:\n",
    "        params = {}\n",
    "    params['limit'] = params.get('limit', 1000)\n",
    "    response = requests.get(OPENFDA_API, params=params)\n",
    "    print(response.url)\n",
    "\n",
    "    if response.status_code != 200:\n",
    "        raise Exception('API response: {}'.format(response.status_code))\n",
    "    return response.json()['results']\n",
    "\n",
    "OPENFDA_METADATA_YAML = \"https://open.fda.gov/fields/drugevent.yaml\"\n",
    "# munch is a yaml parser with javascript-style object access\n",
    "from munch import Munch\n",
    "\n",
    "def api_meta():\n",
    "    \"\"\"\n",
    "    YAML file with field description and other metadata retrieved from the OpenFDA website\n",
    "    Parses YAML file and provides syntactic sugar for accessing nested dictionaries\n",
    "    Example: .patient.properties.patientagegroup.possible_values.value\n",
    "    Note: reserved words, such as count and items still have to be accessed via ['count'], ['items']\n",
    "    \"\"\"\n",
    "    response = requests.get(OPENFDA_METADATA_YAML)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception('Could not retrieve YAML file with drug event API fields')\n",
    "    y = Munch.fromYAML(response.text)\n",
    "    return y['properties']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 511,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['drug', 'patientagegroup', 'patientdeath', 'patientonsetage', 'patientonsetageunit', 'patientsex', 'patientweight', 'reaction', 'summary'])"
      ]
     },
     "execution_count": 511,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "api_meta().patient.properties.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 512,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import datetime\n",
    "\n",
    "start_date = '20110101'\n",
    "end_date = '20110304'\n",
    "\n",
    "\n",
    "# For example, 20100729 is 07/29/2010\"\n",
    "#start_date = input(\"Enter the beginning of your desired date range: \" )\n",
    "#end_date = input(\"Enter the end of your desired date range: \")\n",
    "\n",
    "#country_list = input(\"Enter the countries you would like to limit your search to: \")\n",
    "\n",
    "# create a range of all dates between start and end date\n",
    "my_range = pd.date_range(start=start_date, end=end_date)\n",
    "\n",
    "# reformat the dates to match FAERS\n",
    "f_range = []\n",
    "for dt in my_range:\n",
    "    y = str(dt)[0:4]\n",
    "    m = str(dt)[5:7]\n",
    "    d = str(dt)[8:10]\n",
    "    new_dt = y + m + d\n",
    "    f_range.append(new_dt)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 513,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "https://api.fda.gov/drug/event.json?limit=50&api_key=Og4jAa0KIhPJkiwaxXVD6VHp3DGqoQf37JFPeRct&search=transmissiondate%3A%5B20040101+TO+20150630%5D+AND+patient.reaction.reactionmeddrapt%3A%28%22Heat+exhaustion%22+OR+%22Heat+stroke%22%29\n"
     ]
    }
   ],
   "source": [
    "#safetyreportid of test entry: 10574310\n",
    "\n",
    "columbia_api_key = 'Og4jAa0KIhPJkiwaxXVD6VHp3DGqoQf37JFPeRct'\n",
    "\n",
    "# test strings for API query search fields\n",
    "date_query = 'patient.summary.narrativeincludeclinical:('\n",
    "\n",
    "d_sub = '\"CASE EVENT DATE:'\n",
    "\n",
    "# add each date in range to date_query\n",
    "date_ind = 0\n",
    "num_dates = len(f_range)\n",
    "for ymd in f_range:\n",
    "    date_ind += 1\n",
    "    if date_ind < num_dates:\n",
    "        date_query += d_sub + ymd + '\"' + \" OR \"\n",
    "    else:\n",
    "        date_query += d_sub + ymd + '\"' + \")\"\n",
    "#country_query = 'primarysource.reportercountry:\"FR\"'\n",
    "#country_query = '(primarysource.reportercountry:\"FR\" OR occurcountry:\"FR\" OR primarysourcecountry:\"FR\")'\n",
    "#country_query = 'primarysource.reportercountry:(\"FR\" OR \"DE\" OR \"ES\" OR \"IT\" OR \"CH\")'\n",
    "country_query = 'occurcountry:(\"FR\" OR \"DE\" OR \"ES\" OR \"IT\" OR \"CH\")'\n",
    "reaction_query = 'patient.reaction.reactionmeddrapt:(\"Heat exhaustion\" OR \"Heat stroke\")'\n",
    "\n",
    "\n",
    "#'search': \"receivedate:[20040101 TO 20200101] AND patient.reaction.reactionmeddrapt.exact: {}\".format(\n",
    "\n",
    "\n",
    "test_out = call_api({\n",
    "    'limit': 50,\n",
    "    'api_key': columbia_api_key,\n",
    "    #'search': 'transmissiondate:[20040101 TO 20150630]' + ' AND ' + country_query + ' AND ' + date_query\n",
    "    'search': 'transmissiondate:[20040101 TO 20150630]' + ' AND ' + reaction_query\n",
    "    #'search': 'transmissiondate:[20150630 TO 20150730]' + ' AND ' + country_query\n",
    "    #'search': country_query + ' AND ' + date_query\n",
    "})\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 514,
   "metadata": {},
   "outputs": [],
   "source": [
    "#call_api returns results, which is a list of dictionaries: [ {...}, {...}, {...} ]\n",
    "\n",
    "write_obj = open('results.txt', 'w')\n",
    "write_obj.close()\n",
    "results_obj = open('results.txt', 'a')\n",
    "#results_obj.write(str(x['patient']['drug']))\n",
    "\n",
    "safetyreportid_list = []\n",
    "# iterate through each entry\n",
    "# store safetyreportid\n",
    "# TODO: demographic info?\n",
    "for entry in test_out:\n",
    "    # safetyreportid\n",
    "    results_obj.write(\"report ID: \")\n",
    "    results_obj.write(str(entry['safetyreportid']) + \"\\n\")\n",
    "    safetyreportid_list.append(str(entry['safetyreportid']))\n",
    "\n",
    "    # reportercountry\n",
    "    results_obj.write(\"\\treportercountry: \" + str(entry['primarysource']['reportercountry']) + \"\\n\")\n",
    "\n",
    "    # sex\n",
    "    if 'patientsex' in entry['patient']:\n",
    "        results_obj.write(\"\\tsex: \" + str(entry['patient']['patientsex']) + \"\\n\")\n",
    "\n",
    "    # date\n",
    "    if 'summary' in entry['patient']:\n",
    "        results_obj.write(\"\\t\" + str(entry['patient']['summary']['narrativeincludeclinical']) + \"\\n\")\n",
    "    \n",
    "\n",
    "results_obj.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 515,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# get lines in file that start with the given string\n",
    "# used to search standard_case_drug to find all drugs in a given reportid \n",
    "#def generate_last_cols_lines_that_equal(string, fp, case):\n",
    "def generate_lines_that_equal(string, fp, case):\n",
    "    # iterate through each line in the given file\n",
    "    yielded = set() # for ensuring only non-duplicate drug concepts ids are yielded\n",
    "    for line in fp:\n",
    "        # if there is a match\n",
    "        if line.startswith(string):\n",
    "            # split line by tabs\n",
    "            line_2 = line.strip(\"\\n\")\n",
    "            tab_split = line_2.split('\\t')\n",
    "            # get the last column (concept id) and second to last column (role_cod)\n",
    "            # non-duplicate drug concepts\n",
    "            if case == 0:\n",
    "                lc = tab_split[(len(tab_split)-1)]\n",
    "                # role_cod\n",
    "                rc = tab_split[3]\n",
    "                # ensure no duplicates\n",
    "                if tuple([lc, rc]) in yielded:\n",
    "                    continue\n",
    "                yield [lc, rc]\n",
    "                yielded.add(tuple([lc, rc]))\n",
    "            # RxNorm drug names\n",
    "            elif case == 1:\n",
    "                lc = tab_split[1]\n",
    "                yield lc\n",
    "            # SNOMED outcome concepts from standard_case_outcome\n",
    "            elif case == 2:\n",
    "                lc = tab_split.pop()\n",
    "                yield lc\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 516,
   "metadata": {},
   "outputs": [],
   "source": [
    "# dictionary template for a drug\n",
    "drug_template = { \"drug_concept_id\": None, \"drug_name\": None, \"role_cod\": None, \"KEGG\": {\n",
    "     \"get_URL\": None, \"D_number\": None, \"Classes\": [], \"Target\": [ ], \"Pathway\": None }  \n",
    "    }\n",
    "\n",
    "sub_dict = { \"drugs\": [ ], \"reactions_SNOMED\": [], \"reactions_MedDRA:\": []}\n",
    "# creates a dictionary entry for each id\n",
    "results_dict = dict( (safetyreportid, sub_dict.copy()) for safetyreportid in safetyreportid_list )\n",
    "#print(results_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 517,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# adds a drug subdictionary for each drug for each safetyreportid key\n",
    "def add_AEOLUS_data_to_dictionary(res_dict):\n",
    "    # search standard_case_drug.tsv for each safetyreportid key\n",
    "    # adds drug subdictionary for each drug for each report\n",
    "    with open(\"doi_10.5061_dryad.8q0s4__v1/aeolus_v1/standard_case_drug.tsv\", \"r\") as fp:\n",
    "        for pid in results_dict:\n",
    "            #id_vals = []\n",
    "            # generate a list of drug_ids associated with each safetyreportID\n",
    "            for i in generate_lines_that_equal(str(pid), fp, 0):\n",
    "                template_copy = drug_template.copy()\n",
    "                # assign drug_concept_ids\n",
    "                template_copy['drug_concept_id'] = i[0]\n",
    "                # assign role_cod (primary suspect, secondary suspect, concomitant, etc)\n",
    "                template_copy['role_cod'] = i[1]\n",
    "                drugs_sub_dict_copy = results_dict[pid]['drugs'].copy()\n",
    "                drugs_sub_dict_copy.append(template_copy)\n",
    "                results_dict[pid]['drugs'] = drugs_sub_dict_copy\n",
    "            # go back to beginning of file\n",
    "            fp.seek(0)\n",
    "    # adds outcome for each safetyreportid key by searching standard_case_outcome file\n",
    "    with open(\"doi_10.5061_dryad.8q0s4__v1/aeolus_v1/standard_case_outcome.tsv\") as fp:\n",
    "        for pid in results_dict:\n",
    "            # generate a list of MedDRA reactions and SNOMED reactions associated with each safetyreportID\n",
    "            for i in generate_lines_that_equal(str(pid), fp, 2):\n",
    "                reactions_sub_dict_copy = results_dict[pid]['reactions_SNOMED'].copy()\n",
    "                reactions_sub_dict_copy.append(i)\n",
    "                results_dict[pid]['reactions_SNOMED'] = reactions_sub_dict_copy\n",
    "            # go back to beginning of file\n",
    "            fp.seek(0)\n",
    "        \n",
    "add_AEOLUS_data_to_dictionary(results_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# adds drug names from RxNorm by searching drug concept IDs\n",
    "for pid in results_dict:\n",
    "    for drug in results_dict[pid]['drugs']:\n",
    "        d_id = drug['drug_concept_id']\n",
    "        drug_name_vals = []\n",
    "        # search standard_case_drug for ids\n",
    "        with open(\"RxNorm_vocab/CONCEPT.csv\", \"r\") as fp:\n",
    "            for i in generate_lines_that_equal(d_id, fp, 1):\n",
    "                drug_name_vals.append(i)\n",
    "                drug['drug_name'] = i\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10020013 {'drugs': [{'drug_concept_id': '1112921', 'drug_name': 'ipratropium', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D02212', 'D_number': 'D02212', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist']], 'Target': ['CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]'], 'Pathway': ['hsa04024(1128+1129)  cAMP signaling pathway', 'hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction', 'hsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse']}}, {'drug_concept_id': '1149380', 'drug_name': 'fluticasone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D06315', 'D_number': 'D06315', 'Classes': [['DG02068', 'Glucocorticoid'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3C1 (GR) [HSA:2908] [KO:K05771]'], 'Pathway': ['hsa04080(2908)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1154343', 'drug_name': 'albuterol', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08124', 'D_number': 'D08124', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction']}}], 'reactions_SNOMED': ['\\\\N', '75909', '256722', '373347', '4024567', '140586', '4029966', '255848', '76241'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10025924 {'drugs': [{'drug_concept_id': '1315942', 'drug_name': 'docetaxel', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07866', 'D_number': 'D07866', 'Classes': [['DG02913', 'CYP3A4 substrate']], 'Target': ['TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]'], 'Pathway': ['hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1344905', 'drug_name': 'carboplatin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01363', 'D_number': 'D01363', 'Classes': [['DG01679', 'Platinum compound']], 'Target': ['DNA'], 'Pathway': []}}, {'drug_concept_id': '1314577', 'drug_name': 'nebivolol', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D05127', 'D_number': 'D05127', 'Classes': [['DG03231', 'Antihypertensive'], ['DG01644', 'CYP2D6 substrate']], 'Target': ['ADRB1 [HSA:153] [KO:K04141]'], 'Pathway': ['hsa04080(153)  Neuroactive ligand-receptor interaction', 'hsa04261(153)  Adrenergic signaling in cardiomyocytes', 'Enzyme: CYP2D6 [HSA:1565]']}}, {'drug_concept_id': '1506270', 'drug_name': 'methylprednisolone', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00407', 'D_number': 'D00407', 'Classes': [['DG02068', 'Glucocorticoid'], ['DG03243', 'Atopic dermatitis agent'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3C1 (GR) [HSA:2908] [KO:K05771]'], 'Pathway': ['hsa04080(2908)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1501700', 'drug_name': 'levothyroxine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D11113', 'D_number': 'D11113', 'Classes': [['DG01608', 'Thyroid hormone replenisher']], 'Target': ['NR1A (THR) [HSA:7067 7068] [KO:K05547 K08362]'], 'Pathway': ['hsa04080(7067+7068)  Neuroactive ligand-receptor interaction', 'hsa04919(7067+7068)  Thyroid hormone signaling pathway']}}], 'reactions_SNOMED': ['4086587', '137193', '140586', '4090424'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10085688 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '745466', 'drug_name': 'valproate', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00304', 'D_number': 'D00304', 'Classes': [['DG01573', 'Calcium channel T type blocker'], ['DG02035', 'Fatty acid antiepileptic']], 'Target': ['ABAT [HSA:18] [KO:K13524]', 'SSADH [HSA:7915] [KO:K00139]', 'GAD [HSA:2571 2572] [KO:K01580]', 'CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]'], 'Pathway': ['hsa04020(8911+8912+8913)  Calcium signaling pathway', 'hsa04727(18+2571+2572)  GABAergic synapse']}}, {'drug_concept_id': '40063306', 'drug_name': 'metformin / rosiglitazone Oral Tablet', 'role_cod': 'C', 'KEGG': 'No entry'}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10151788 {'drugs': [{'drug_concept_id': '1151789', 'drug_name': 'etanercept', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00742', 'D_number': 'D00742', 'Classes': [['DG01936', 'TNF inhibitor']], 'Target': ['TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]', 'LTA (TNFB, TNFSF1) [HSA:4049] [KO:K05468]'], 'Pathway': ['hsa04010(7124)  MAPK signaling pathway', 'hsa04060(4049+7124)  Cytokine-cytokine receptor interaction', 'hsa04064(4049+7124)  NF-kappa B signaling pathway', 'hsa04210(7124)  Apoptosis', 'hsa04350(7124)  TGF-beta signaling pathway', 'hsa04380(7124)  Osteoclast differentiation', 'hsa04612(7124)  Antigen processing and presentation', 'hsa04920(7124)  Adipocytokine signaling pathway', 'hsa05323(7124)  Rheumatoid arthritis']}}], 'reactions_SNOMED': ['133280', '437113', '196523', '4223938', '375527', '140586', '442752', '31967', '4079185', '441408'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10153358 {'drugs': [{'drug_concept_id': '722424', 'drug_name': 'interferon beta-1a', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D10483', 'D_number': 'D10483', 'Classes': [['DG01752', 'Interferone']], 'Target': ['IFNAR1 [HSA:3454] [KO:K05130]', 'IFNAR2 [HSA:3455] [KO:K05131]'], 'Pathway': ['hsa04060(3454+3455)  Cytokine-cytokine receptor interaction', 'hsa04620(3454+3455)  Toll-like receptor signaling pathway', 'hsa04630(3454+3455)  JAK-STAT signaling pathway', 'hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity']}}, {'drug_concept_id': '722424', 'drug_name': 'interferon beta-1a', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D10483', 'D_number': 'D10483', 'Classes': [['DG01752', 'Interferone']], 'Target': ['IFNAR1 [HSA:3454] [KO:K05130]', 'IFNAR2 [HSA:3455] [KO:K05131]'], 'Pathway': ['hsa04060(3454+3455)  Cytokine-cytokine receptor interaction', 'hsa04620(3454+3455)  Toll-like receptor signaling pathway', 'hsa04630(3454+3455)  JAK-STAT signaling pathway', 'hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity']}}], 'reactions_SNOMED': ['\\\\N', '4071366', '317009', '73819', '442165', '140586', '4042563', '4275882', '4319159', '74052', '4272240', '4224178', '31967', '4320791', '4152347', '441408'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10184459 {'drugs': [{'drug_concept_id': '735843', 'drug_name': 'natalizumab', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D06886', 'D_number': 'D06886', 'Classes': [], 'Target': ['ITGA4 (CD49D) [HSA:3676] [KO:K06483]'], 'Pathway': ['hsa04512(3676)  ECM-receptor interaction', 'hsa04670(3676)  Leukocyte transendothelial migration']}}], 'reactions_SNOMED': ['\\\\N', '377091', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10185517 {'drugs': [{'drug_concept_id': '42900584', 'drug_name': 'teriflunomide', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D10172', 'D_number': 'D10172', 'Classes': [], 'Target': ['DHODH [HSA:1723] [KO:K00254]'], 'Pathway': ['hsa00240(1723)  Pyrimidine metabolism']}}], 'reactions_SNOMED': ['440213', '4239038', '435796', '436093', '441830', '201340', '140586', '140821', '4187218', '137967'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10197970 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '435242', '140586', '434610', '316866', '4208994', '4245042', '4050941', '441553', '378165', '444419', '444070', '317376'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10222368 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '436093', '4340781', '140586', '317002', '193355', '197320', '4291649'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10227575 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '436093', '4340781', '140586', '317002', '193355', '4212484', '197320', '4291649'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10232590 {'drugs': [{'drug_concept_id': '904453', 'drug_name': 'esomeprazole', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07917', 'D_number': 'D07917', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa00190(495+496)  Oxidative phosphorylation', 'hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '904453', 'drug_name': 'esomeprazole', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07917', 'D_number': 'D07917', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa00190(495+496)  Oxidative phosphorylation', 'hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '19039926', 'drug_name': 'dexlansoprazole', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08903', 'D_number': 'D08903', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate'], ['DG01933', 'CYP2C19 inhibitor']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1367500', 'drug_name': 'losartan', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08146', 'D_number': 'D08146', 'Classes': [['DG01495', 'Angiotensin II receptor antagonist'], ['DG01642', 'CYP2C9 substrate']], 'Target': ['AGTR1 [HSA:185] [KO:K04166]'], 'Pathway': ['hsa04080(185)  Neuroactive ligand-receptor interaction', 'hsa04261(185)  Adrenergic signaling in cardiomyocytes', 'hsa04270(185)  Vascular smooth muscle contraction', 'hsa04614(185)  Renin-angiotensin system', 'Enzyme: CYP2C9 [HSA:1559]']}}, {'drug_concept_id': '1112807', 'drug_name': 'aspirin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D03385', 'D_number': 'D03385', 'Classes': [['DG01712', 'Antiplatelet agent'], ['DG01909', 'Anti-inflammatory drug, salicylic acid derivatives']], 'Target': [], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '437113', '437744', '4272240', '31967', '441408'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10239703 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '436093', '4340781', '140586', '317002', '193355', '197320', '4291649'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10240593 {'drugs': [{'drug_concept_id': '19100985', 'drug_name': 'panitumumab', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D05350', 'D_number': 'D05350', 'Classes': [['DG03162', 'EGFR inhibitor']], 'Target': ['EGFR [HSA:1956] [KO:K04361]'], 'Pathway': ['hsa04010(1956)  MAPK signaling pathway', 'hsa04012(1956)  ErbB signaling pathway', 'hsa05200(1956)  Pathways in cancer']}}], 'reactions_SNOMED': ['\\\\N', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10258737 {'drugs': [{'drug_concept_id': '916005', 'drug_name': 'solifenacin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01269', 'D_number': 'D01269', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '916005', 'drug_name': 'solifenacin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01269', 'D_number': 'D01269', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['140586', '192450'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10260965 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '4175340', '436093', '4340781', '192671', '140586', '317002', '193355', '197320'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10277071 {'drugs': [{'drug_concept_id': '1351115', 'drug_name': 'ubidecarenone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01065', 'D_number': 'D01065', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '19011773', 'drug_name': 'ascorbic acid', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00018', 'D_number': 'D00018', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '19008339', 'drug_name': 'vitamin A', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00100', 'D_number': 'D00100', 'Classes': [['DG01603', 'Vitamin K'], ['DG03232', 'Osteoporosis agent']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '19009405', 'drug_name': 'vitamin D', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00100', 'D_number': 'D00100', 'Classes': [['DG01603', 'Vitamin K'], ['DG03232', 'Osteoporosis agent']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '916005', 'drug_name': 'solifenacin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01269', 'D_number': 'D01269', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '916005', 'drug_name': 'solifenacin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01269', 'D_number': 'D01269', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1360332', 'drug_name': 'glucosamine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D04334', 'D_number': 'D04334', 'Classes': [], 'Target': [], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '381273', '75860', '435796', '4052648', '4327654', '195562', '140586', '4154784', '442752', '192450'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10277585 {'drugs': [{'drug_concept_id': '757688', 'drug_name': 'aripiprazole', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01164', 'D_number': 'D01164', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'DRD3 [HSA:1814] [KO:K04146]', 'HTR1A [HSA:3350] [KO:K04153]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+1814+3350+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3350+3356)  Serotonergic synapse', 'hsa04728(1813+1814)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]']}}], 'reactions_SNOMED': ['140586', '255848'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10291524 {'drugs': [{'drug_concept_id': '1133201', 'drug_name': 'buprenorphine', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07132', 'D_number': 'D07132', 'Classes': [['DG01586', 'Opioid receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['OPRK1 [HSA:4986] [KO:K04214]', 'OPRM1 [HSA:4988] [KO:K04215]'], 'Pathway': ['hsa04080(4986+4988)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '4318383', '4319311', '4223938', '437744', '138565', '31967'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10292628 {'drugs': [{'drug_concept_id': '1133201', 'drug_name': 'buprenorphine', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07132', 'D_number': 'D07132', 'Classes': [['DG01586', 'Opioid receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['OPRK1 [HSA:4986] [KO:K04214]', 'OPRM1 [HSA:4988] [KO:K04215]'], 'Pathway': ['hsa04080(4986+4988)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10301206 {'drugs': [{'drug_concept_id': '1548195', 'drug_name': 'estradiol', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00105', 'D_number': 'D00105', 'Classes': [['DG01584', 'Estrogen receptor agonist'], ['DG03232', 'Osteoporosis agent'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]'], 'Pathway': ['hsa04915(2099+2100)  Estrogen signaling pathway', 'hsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1154029', 'drug_name': 'fentanyl', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00320', 'D_number': 'D00320', 'Classes': [['DG01563', 'mu-Opioid receptor agonist'], ['DG01984', 'Opioid analgesics'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['OPRM1 [HSA:4988] [KO:K04215]'], 'Pathway': ['hsa04080(4988)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '381316', '4276665', '4162724', '140586', '138565'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10301801 {'drugs': [{'drug_concept_id': '42900505', 'drug_name': 'linaclotide', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D06612', 'D_number': 'D06612', 'Classes': [['DG01770', 'Laxative']], 'Target': ['GUCY2C [HSA:2984] [KO:K12320]'], 'Pathway': []}}], 'reactions_SNOMED': ['4223938', '439926', '140586', '4113666'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10314922 {'drugs': [{'drug_concept_id': '904453', 'drug_name': 'esomeprazole', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07917', 'D_number': 'D07917', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa00190(495+496)  Oxidative phosphorylation', 'hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['4223938', '140586', '31967', '436817'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10332098 {'drugs': [{'drug_concept_id': '40166942', 'drug_name': 'calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution', 'role_cod': 'PS', 'KEGG': 'No entry'}, {'drug_concept_id': '40166942', 'drug_name': 'calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution', 'role_cod': 'SS', 'KEGG': 'No entry'}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10340496 {'drugs': [{'drug_concept_id': '791967', 'drug_name': 'lorazepam', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00365', 'D_number': 'D00365', 'Classes': [['DG03199', 'Antiepileptic agent'], ['DG03187', 'UGT2B15 substrate']], 'Target': ['GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]'], 'Pathway': ['hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse', 'Enzyme: UGT2B7 [HSA:7364], UGT2B15 [HSA:7366]']}}, {'drug_concept_id': '1149196', 'drug_name': 'cetirizine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07402', 'D_number': 'D07402', 'Classes': [['DG01482', 'Histamine receptor H1 antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['HRH1 [HSA:3269] [KO:K04149]'], 'Pathway': ['hsa04080(3269)  Neuroactive ligand-receptor interaction', 'hsa04750(3269)  Inflammatory mediator regulation of TRP channels', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '703547', 'drug_name': 'trazodone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08626', 'D_number': 'D08626', 'Classes': [['DG03056', 'Serotonin antagonist and reuptake inhibitor (SARI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['SLC6A4 (HTT) [HSA:6532] [KO:K05037]', 'HTR2 [HSA:3356 3357 3358] [KO:K04157]'], 'Pathway': ['hsa04080(3356+3357+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(3356+3357+3358+6532)  Serotonergic synapse', 'Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]']}}, {'drug_concept_id': '1506270', 'drug_name': 'methylprednisolone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00407', 'D_number': 'D00407', 'Classes': [['DG02068', 'Glucocorticoid'], ['DG03243', 'Atopic dermatitis agent'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3C1 (GR) [HSA:2908] [KO:K05771]'], 'Pathway': ['hsa04080(2908)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1322184', 'drug_name': 'clopidogrel', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07729', 'D_number': 'D07729', 'Classes': [['DG01808', 'Thienopyridine'], ['DG02913', 'CYP3A4 substrate'], ['DG01641', 'CYP2C8 inhibitor']], 'Target': ['P2RY12 [HSA:64805] [KO:K04298]', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2B6 [HSA:1555]'], 'Pathway': []}}, {'drug_concept_id': '1334456', 'drug_name': 'ramipril', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00421', 'D_number': 'D00421', 'Classes': [['DG01501', 'Angiotensin-converting enzyme inhibitor']], 'Target': ['ACE (CD143) [HSA:1636] [KO:K01283]'], 'Pathway': ['hsa04614(1636)  Renin-angiotensin system']}}, {'drug_concept_id': '956874', 'drug_name': 'furosemide', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00331', 'D_number': 'D00331', 'Classes': [['DG01747', 'Furosemide type diuretic'], ['DG02860', 'SLC22A8 substrate']], 'Target': ['SLC12A1 (NKCC2) [HSA:6557] [KO:K14425]', 'SLC12A2 (NKCC1) [HSA:6558] [KO:K10951]', 'Transporter: SLC22A6 [HSA:9356], SLC22A8 [HSA:9376], ABCC4 [HSA:10257]'], 'Pathway': []}}], 'reactions_SNOMED': ['140586', '4232311', '135360'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10345902 {'drugs': [{'drug_concept_id': '1151789', 'drug_name': 'etanercept', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00742', 'D_number': 'D00742', 'Classes': [['DG01936', 'TNF inhibitor']], 'Target': ['TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]', 'LTA (TNFB, TNFSF1) [HSA:4049] [KO:K05468]'], 'Pathway': ['hsa04010(7124)  MAPK signaling pathway', 'hsa04060(4049+7124)  Cytokine-cytokine receptor interaction', 'hsa04064(4049+7124)  NF-kappa B signaling pathway', 'hsa04210(7124)  Apoptosis', 'hsa04350(7124)  TGF-beta signaling pathway', 'hsa04380(7124)  Osteoclast differentiation', 'hsa04612(7124)  Antigen processing and presentation', 'hsa04920(7124)  Adipocytokine signaling pathway', 'hsa05323(7124)  Rheumatoid arthritis']}}], 'reactions_SNOMED': ['436583', '375415', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10352353 {'drugs': [{'drug_concept_id': '1501700', 'drug_name': 'levothyroxine', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D11113', 'D_number': 'D11113', 'Classes': [['DG01608', 'Thyroid hormone replenisher']], 'Target': ['NR1A (THR) [HSA:7067 7068] [KO:K05547 K08362]'], 'Pathway': ['hsa04080(7067+7068)  Neuroactive ligand-receptor interaction', 'hsa04919(7067+7068)  Thyroid hormone signaling pathway']}}, {'drug_concept_id': '1501700', 'drug_name': 'levothyroxine', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D11113', 'D_number': 'D11113', 'Classes': [['DG01608', 'Thyroid hormone replenisher']], 'Target': ['NR1A (THR) [HSA:7067 7068] [KO:K05547 K08362]'], 'Pathway': ['hsa04080(7067+7068)  Neuroactive ligand-receptor interaction', 'hsa04919(7067+7068)  Thyroid hormone signaling pathway']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '\\\\N', '4086587', '434490', '4276665', '4162724', '437744', '436962', '4154927', '4056883', '140214', '4152347', '437985', '4079185'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10354933 {'drugs': [{'drug_concept_id': '1557272', 'drug_name': 'alendronate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00939', 'D_number': 'D00939', 'Classes': [['DG01600', 'Bisphosphonate']], 'Target': ['FDPS [HSA:2224] [KO:K00787]'], 'Pathway': ['hsa00900(2224)  Terpenoid backbone biosynthesis']}}], 'reactions_SNOMED': ['140586', '4161682'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10356294 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '40063306', 'drug_name': 'metformin / rosiglitazone Oral Tablet', 'role_cod': 'C', 'KEGG': 'No entry'}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10357536 {'drugs': [{'drug_concept_id': '40166942', 'drug_name': 'calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution', 'role_cod': 'SS', 'KEGG': 'No entry'}, {'drug_concept_id': '40166942', 'drug_name': 'calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution', 'role_cod': 'PS', 'KEGG': 'No entry'}], 'reactions_SNOMED': ['313217', '140586', '318459'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10358718 {'drugs': [{'drug_concept_id': '1106776', 'drug_name': 'tiotropium', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01929', 'D_number': 'D01929', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse']}}], 'reactions_SNOMED': ['4024567', '140586', '4161682', '444070'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10363868 {'drugs': [{'drug_concept_id': '1322184', 'drug_name': 'clopidogrel', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07729', 'D_number': 'D07729', 'Classes': [['DG01808', 'Thienopyridine'], ['DG02913', 'CYP3A4 substrate'], ['DG01641', 'CYP2C8 inhibitor']], 'Target': ['P2RY12 [HSA:64805] [KO:K04298]', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2B6 [HSA:1555]'], 'Pathway': []}}, {'drug_concept_id': '956874', 'drug_name': 'furosemide', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00331', 'D_number': 'D00331', 'Classes': [['DG01747', 'Furosemide type diuretic'], ['DG02860', 'SLC22A8 substrate']], 'Target': ['SLC12A1 (NKCC2) [HSA:6557] [KO:K14425]', 'SLC12A2 (NKCC1) [HSA:6558] [KO:K10951]', 'Transporter: SLC22A6 [HSA:9356], SLC22A8 [HSA:9376], ABCC4 [HSA:10257]'], 'Pathway': []}}, {'drug_concept_id': '1334456', 'drug_name': 'ramipril', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00421', 'D_number': 'D00421', 'Classes': [['DG01501', 'Angiotensin-converting enzyme inhibitor']], 'Target': ['ACE (CD143) [HSA:1636] [KO:K01283]'], 'Pathway': ['hsa04614(1636)  Renin-angiotensin system']}}, {'drug_concept_id': '703547', 'drug_name': 'trazodone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08626', 'D_number': 'D08626', 'Classes': [['DG03056', 'Serotonin antagonist and reuptake inhibitor (SARI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['SLC6A4 (HTT) [HSA:6532] [KO:K05037]', 'HTR2 [HSA:3356 3357 3358] [KO:K04157]'], 'Pathway': ['hsa04080(3356+3357+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(3356+3357+3358+6532)  Serotonergic synapse', 'Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]']}}], 'reactions_SNOMED': ['140586', '4232311', '135360'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10363961 {'drugs': [{'drug_concept_id': '44785094', 'drug_name': 'sofosbuvir', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D10366', 'D_number': 'D10366', 'Classes': [['DG02000', 'HCV NS5B polymerase inhibitor'], ['DG01913', 'ABCG2 substrate']], 'Target': ['HCV NS5B polymerase [KO:K22472]'], 'Pathway': ['ko03230(K22472)  Viral genome structure', 'ko03240(K22472)  Viral replication', 'ko05160(K22472)  Hepatitis C', 'Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]']}}, {'drug_concept_id': '1762711', 'drug_name': 'ribavirin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00423', 'D_number': 'D00423', 'Classes': [['DG02000', 'HCV NS5B polymerase inhibitor']], 'Target': ['HCV NS5B polymerase [KO:K22472]'], 'Pathway': ['ko03230(K22472)  Viral genome structure', 'ko03240(K22472)  Viral replication', 'ko05160(K22472)  Hepatitis C']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '437113', '435796', '196523', '436667', '4147189', '439926', '4162724', '375527', '437744', '138565', '4318719', '372448', '140821', '138525', '437663', '377575', '432941', '439977', '435928'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10364041 {'drugs': [{'drug_concept_id': '1151789', 'drug_name': 'etanercept', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00742', 'D_number': 'D00742', 'Classes': [['DG01936', 'TNF inhibitor']], 'Target': ['TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]', 'LTA (TNFB, TNFSF1) [HSA:4049] [KO:K05468]'], 'Pathway': ['hsa04010(7124)  MAPK signaling pathway', 'hsa04060(4049+7124)  Cytokine-cytokine receptor interaction', 'hsa04064(4049+7124)  NF-kappa B signaling pathway', 'hsa04210(7124)  Apoptosis', 'hsa04350(7124)  TGF-beta signaling pathway', 'hsa04380(7124)  Osteoclast differentiation', 'hsa04612(7124)  Antigen processing and presentation', 'hsa04920(7124)  Adipocytokine signaling pathway', 'hsa05323(7124)  Rheumatoid arthritis']}}], 'reactions_SNOMED': ['375527', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10370403 {'drugs': [{'drug_concept_id': '1196677', 'drug_name': 'formoterol', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07463', 'D_number': 'D07463', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction']}}, {'drug_concept_id': '1154343', 'drug_name': 'albuterol', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08124', 'D_number': 'D08124', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction']}}, {'drug_concept_id': '1112921', 'drug_name': 'ipratropium', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D02212', 'D_number': 'D02212', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist']], 'Target': ['CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]'], 'Pathway': ['hsa04024(1128+1129)  cAMP signaling pathway', 'hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction', 'hsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse']}}], 'reactions_SNOMED': ['4024567', '437744', '4161682', '444070'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10371125 {'drugs': [{'drug_concept_id': '920293', 'drug_name': 'nitrofurantoin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00439', 'D_number': 'D00439', 'Classes': [['DG01552', 'Hydantoin type nitrofuran']], 'Target': [], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '434490', '140586', '441408'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10387545 {'drugs': [{'drug_concept_id': '1549786', 'drug_name': 'ethinyl estradiol', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00554', 'D_number': 'D00554', 'Classes': [['DG01584', 'Estrogen receptor agonist'], ['DG02913', 'CYP3A4 substrate'], ['DG01522', 'CYP3A4 inhibitor']], 'Target': ['NR3A1 (ESR1) [HSA:2099] [KO:K08550]'], 'Pathway': ['hsa04915(2099)  Estrogen signaling pathway', 'hsa05200(2099)  Pathways in cancer', 'hsa05224(2099)  Breast cancer', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '441542', '4090870', '4133004', '375527', '140586', '4319450', '440417'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10392544 {'drugs': [{'drug_concept_id': '991382', 'drug_name': 'amiloride', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07447', 'D_number': 'D07447', 'Classes': [['DG01885', 'Potassium-sparing diuretic']], 'Target': ['SCNN1 [HSA:6337 6338 6340] [KO:K04824 K04825 K04827]'], 'Pathway': ['hsa04960(6337+6338+6340)  Aldosterone-regulated sodium reabsorption']}}, {'drug_concept_id': '725131', 'drug_name': 'mirtazapine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00563', 'D_number': 'D00563', 'Classes': [['DG01460', 'alpha2-Adrenergic receptor antagonist'], ['DG03077', 'Noradrenergic and specific serotonergic antidepressant (NaSSA)'], ['DG01489', '5-HT3-receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['HTR2 [HSA:3356 3357 3358] [KO:K04157]', 'HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]', 'ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]'], 'Pathway': ['hsa04080(150+151+152+3356+3357+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(170572+200909+285242+3356+3357+3358+3359+9177)  Serotonergic synapse', 'Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1178663', 'drug_name': 'indomethacin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00141', 'D_number': 'D00141', 'Classes': [['DG01899', 'Anti-inflammatory drug, indoleacetic acid derivatives']], 'Target': ['PTGS1 (COX1) [HSA:5742] [KO:K00509]', 'PTGS2 (COX2) [HSA:5743] [KO:K11987]'], 'Pathway': ['hsa00590(5742+5743)  Arachidonic acid metabolism']}}, {'drug_concept_id': '1332418', 'drug_name': 'amlodipine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07450', 'D_number': 'D07450', 'Classes': [['DG01928', 'Dihydropyridine calcium channel blocker'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04260(775+776+778+779)  Cardiac muscle contraction', 'hsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes', 'hsa04270(775+776+778+779)  Vascular smooth muscle contraction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '19095002', 'drug_name': 'chlorprothixene', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00790', 'D_number': 'D00790', 'Classes': [], 'Target': ['DRD1 [HSA:1812] [KO:K04144]', 'DRD2 [HSA:1813] [KO:K04145]'], 'Pathway': ['hsa04080(1812+1813)  Neuroactive ligand-receptor interaction', 'hsa04728(1812+1813)  Dopaminergic synapse']}}, {'drug_concept_id': '800878', 'drug_name': 'clozapine', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00283', 'D_number': 'D00283', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['HTR2A [HSA:3356] [KO:K04157]', 'HTR2C [HSA:3358] [KO:K04157]', 'HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]', 'ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]', 'DRD4 [HSA:1815] [KO:K04147]'], 'Pathway': ['hsa04080(150+151+152+1815+3356+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(170572+200909+285242+3356+3358+3359+9177)  Serotonergic synapse', 'hsa04728(1815)  Dopaminergic synapse', 'Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1503297', 'drug_name': 'metformin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D04966', 'D_number': 'D04966', 'Classes': [['DG01684', 'Biguanide antidiabetic']], 'Target': ['AMPK (PRKAA) [HSA:5562 5563] [KO:K07198]'], 'Pathway': ['hsa04152(5562+5563)  AMPK signaling pathway', 'hsa04910(5562+5563)  Insulin signaling pathway', 'hsa04920(5562+5563)  Adipocytokine signaling pathway']}}, {'drug_concept_id': '800878', 'drug_name': 'clozapine', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00283', 'D_number': 'D00283', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['HTR2A [HSA:3356] [KO:K04157]', 'HTR2C [HSA:3358] [KO:K04157]', 'HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]', 'ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]', 'DRD4 [HSA:1815] [KO:K04147]'], 'Pathway': ['hsa04080(150+151+152+1815+3356+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(170572+200909+285242+3356+3358+3359+9177)  Serotonergic synapse', 'hsa04728(1815)  Dopaminergic synapse', 'Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '924566', 'drug_name': 'tamsulosin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08560', 'D_number': 'D08560', 'Classes': [['DG01457', 'alpha1-Adrenergic receptor antagonist']], 'Target': ['ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]'], 'Pathway': ['hsa04022(146+147+148)  cGMP-PKG signaling pathway', 'hsa04080(146+147+148)  Neuroactive ligand-receptor interaction', 'hsa04270(146+147+148)  Vascular smooth muscle contraction']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '256722', '140586', '379802', '437985', '4028970'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10393445 {'drugs': [{'drug_concept_id': '42709324', 'drug_name': 'vitamin D3', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00188', 'D_number': 'D00188', 'Classes': [['DG01607', 'Vitamin D derivatives']], 'Target': ['NR1I1 (VDR) [HSA:7421] [KO:K08539]'], 'Pathway': ['hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption', 'hsa04978(7421)  Mineral absorption']}}, {'drug_concept_id': '19111620', 'drug_name': 'folic acid', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00070', 'D_number': 'D00070', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '1125315', 'drug_name': 'acetaminophen', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00217', 'D_number': 'D00217', 'Classes': [['DG01981', 'Anilide derivative, anti-inflammatory']], 'Target': ['PTGS1 (COX1) [HSA:5742] [KO:K00509]', 'PTGS2 (COX2) [HSA:5743] [KO:K11987]'], 'Pathway': ['hsa00590(5742+5743)  Arachidonic acid metabolism']}}, {'drug_concept_id': '40165651', 'drug_name': 'onabotulinumtoxinA', 'role_cod': 'C', 'KEGG': 'No entry'}, {'drug_concept_id': '19062817', 'drug_name': 'riboflavin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00050', 'D_number': 'D00050', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '778711', 'drug_name': 'cyclobenzaprine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07758', 'D_number': 'D07758', 'Classes': [['DG01974', 'Centrally acting muscle relaxant']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '42900311', 'drug_name': 'cinnamon oil, leaf', 'role_cod': 'C', 'KEGG': 'No entry'}, {'drug_concept_id': '19008339', 'drug_name': 'vitamin A', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00100', 'D_number': 'D00100', 'Classes': [['DG01603', 'Vitamin K'], ['DG03232', 'Osteoporosis agent']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '42900581', 'drug_name': 'tumeric oil', 'role_cod': 'C', 'KEGG': 'No entry'}, {'drug_concept_id': '1308216', 'drug_name': 'lisinopril', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08131', 'D_number': 'D08131', 'Classes': [['DG01501', 'Angiotensin-converting enzyme inhibitor']], 'Target': ['ACE (CD143) [HSA:1636] [KO:K01283]'], 'Pathway': ['hsa04614(1636)  Renin-angiotensin system']}}, {'drug_concept_id': '1149380', 'drug_name': 'fluticasone', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D06315', 'D_number': 'D06315', 'Classes': [['DG02068', 'Glucocorticoid'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3C1 (GR) [HSA:2908] [KO:K05771]'], 'Pathway': ['hsa04080(2908)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1734104', 'drug_name': 'azithromycin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07486', 'D_number': 'D07486', 'Classes': [['DG01875', '15-Membered ring macrolide antibiotic'], ['DG01665', 'ABCB1 substrate'], ['DG01622', 'ABCB1 inhibitor']], 'Target': ['50S ribosomal subunit'], 'Pathway': ['ko03010(K01980)  Ribosome', 'Transporter: ABCB1 [HSA:5243]']}}, {'drug_concept_id': '40137949', 'drug_name': 'acetaminophen / aspirin / caffeine Oral Powder', 'role_cod': 'C', 'KEGG': 'No entry'}, {'drug_concept_id': '752061', 'drug_name': 'prochlorperazine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00493', 'D_number': 'D00493', 'Classes': [['DG01905', 'Phenothiazine antipsychotics']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]'], 'Pathway': ['hsa04080(1813)  Neuroactive ligand-receptor interaction', 'hsa04728(1813)  Dopaminergic synapse']}}, {'drug_concept_id': '1112807', 'drug_name': 'aspirin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D03385', 'D_number': 'D03385', 'Classes': [['DG01712', 'Antiplatelet agent'], ['DG01909', 'Anti-inflammatory drug, salicylic acid derivatives']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '1539403', 'drug_name': 'simvastatin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00434', 'D_number': 'D00434', 'Classes': [['DG01660', 'HMG-CoA reductase inhibitor'], ['DG02913', 'CYP3A4 substrate'], ['DG02856', 'SLCO1B1 substrate']], 'Target': ['HMGCR [HSA:3156] [KO:K00021]'], 'Pathway': ['hsa00900(3156)  Terpenoid backbone biosynthesis', 'Enzyme: CYP3A4 [HSA:1576]', 'Transporter: SLCO1B1 [HSA:10599]']}}, {'drug_concept_id': '705103', 'drug_name': 'lamotrigine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00354', 'D_number': 'D00354', 'Classes': [['DG03199', 'Antiepileptic agent'], ['DG03182', 'UGT1A4 substrate']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: UGT1A4 [HSA:54657]']}}, {'drug_concept_id': '1137529', 'drug_name': 'salmeterol', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D05792', 'D_number': 'D05792', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1154343', 'drug_name': 'albuterol', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08124', 'D_number': 'D08124', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction']}}, {'drug_concept_id': '19011773', 'drug_name': 'ascorbic acid', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00018', 'D_number': 'D00018', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '710062', 'drug_name': 'amitriptyline', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07448', 'D_number': 'D07448', 'Classes': [['DG01728', 'Tricyclic antidepressant'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['SLC6A4 (HTT) [HSA:6532] [KO:K05037]', 'SLC6A2 (NAT1) [HSA:6530] [KO:K05035]'], 'Pathway': ['hsa04721(6530+6532)  Synaptic vesicle cycle', 'hsa04726(6532)  Serotonergic synapse', 'Enzyme: CYP2D6 [HSA:1565]; CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]']}}, {'drug_concept_id': '743670', 'drug_name': 'venlafaxine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07793', 'D_number': 'D07793', 'Classes': [['DG01658', 'Serotonin and norepinephrine reuptake inhibitor (SNRI)'], ['DG02924', 'UGT substrate']], 'Target': ['SLC6A4 (HTT) [HSA:6532] [KO:K05037]', 'SLC6A2 (NAT1) [HSA:6530] [KO:K05035]'], 'Pathway': ['hsa04721(6530+6532)  Synaptic vesicle cycle', 'hsa04726(6532)  Serotonergic synapse', 'Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]']}}, {'drug_concept_id': '911735', 'drug_name': 'rabeprazole', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08463', 'D_number': 'D08463', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '433128', '317002', '4086587', '256451', '77670', '195588', '4033051', '196523', '4223938', '197913', '4024567', '4302537', '437744', '192964', '4028389', '318736', '31967', '4329041', '255848', '441408', '435928'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10403686 {'drugs': [{'drug_concept_id': '1636780', 'drug_name': 'testosterone', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00408', 'D_number': 'D00408', 'Classes': [['DG02006', 'Testosterone']], 'Target': ['NR3C4 (AR) [HSA:367] [KO:K08557]'], 'Pathway': ['hsa04114(367)  Oocyte meiosis', 'hsa05200(367)  Pathways in cancer']}}], 'reactions_SNOMED': ['\\\\N', '4319311', '439926', '140586', '138565'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10409393 {'drugs': [{'drug_concept_id': '713196', 'drug_name': 'interferon beta-1b', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00746', 'D_number': 'D00746', 'Classes': [['DG01752', 'Interferone']], 'Target': ['IFNAR1 [HSA:3454] [KO:K05130]', 'IFNAR2 [HSA:3455] [KO:K05131]'], 'Pathway': ['hsa04060(3454+3455)  Cytokine-cytokine receptor interaction', 'hsa04620(3454+3455)  Toll-like receptor signaling pathway', 'hsa04630(3454+3455)  JAK-STAT signaling pathway', 'hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity']}}, {'drug_concept_id': '705944', 'drug_name': 'methylphenidate', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D04999', 'D_number': 'D04999', 'Classes': [], 'Target': ['SLC6A3 (DAT1) [HSA:6531] [KO:K05036]', 'SLC6A2 (NAT1) [HSA:6530] [KO:K05035]'], 'Pathway': ['hsa04721(6530+6531)  Synaptic vesicle cycle', 'hsa04728(6531)  Dopaminergic synapse']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '441207', '438557', '437643', '437744', '4316207', '79908'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10417536 {'drugs': [{'drug_concept_id': '43526424', 'drug_name': 'dimethyl fumarate', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D03846', 'D_number': 'D03846', 'Classes': [], 'Target': ['KEAP1 [HSA:9817] [KO:K10456]'], 'Pathway': []}}, {'drug_concept_id': '43526424', 'drug_name': 'dimethyl fumarate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D03846', 'D_number': 'D03846', 'Classes': [], 'Target': ['KEAP1 [HSA:9817] [KO:K10456]'], 'Pathway': []}}], 'reactions_SNOMED': ['437113', '318566', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10422942 {'drugs': [{'drug_concept_id': '723013', 'drug_name': 'diazepam', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00293', 'D_number': 'D00293', 'Classes': [['DG03199', 'Antiepileptic agent'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]'], 'Pathway': ['hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse', 'Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '798874', 'drug_name': 'clonazepam', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00280', 'D_number': 'D00280', 'Classes': [['DG02036', 'Benzodiazepine derivative, antiepileptic']], 'Target': ['GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]'], 'Pathway': ['hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse']}}], 'reactions_SNOMED': ['4099943', '441260', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10435129 {'drugs': [{'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '436093', '4340781', '444070', '140586', '317002', '193355', '4212484', '197320', '4291649'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10444519 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10456262 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10456952 {'drugs': [{'drug_concept_id': '1321636', 'drug_name': 'bosentan', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07538', 'D_number': 'D07538', 'Classes': [['DG01502', 'Endothelin receptor antagonist'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer']], 'Target': ['EDNR [HSA:1909 1910] [KO:K04197 K04198]'], 'Pathway': ['hsa04080(1909+1910)  Neuroactive ligand-receptor interaction', 'hsa04270(1909)  Vascular smooth muscle contraction', 'Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['4024567', '437744'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10473904 {'drugs': [{'drug_concept_id': '1318011', 'drug_name': 'oxaliplatin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01790', 'D_number': 'D01790', 'Classes': [['DG01679', 'Platinum compound'], ['DG02854', 'SLC22A2 substrate']], 'Target': ['DNA', 'Transporter: SLC22A2 [HSA:6582], SLC22A1 [HSA:6580]'], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '4024567', '140586', '433595'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10486791 {'drugs': [{'drug_concept_id': '785788', 'drug_name': 'olanzapine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00454', 'D_number': 'D00454', 'Classes': [['DG01457', 'alpha1-Adrenergic receptor antagonist'], ['DG03064', 'Atypical antipsychotic'], ['DG01482', 'Histamine receptor H1 antagonist'], ['DG01644', 'CYP2D6 substrate']], 'Target': ['HTR2 [HSA:3356 3357 3358] [KO:K04157]', 'HTR6 [HSA:3362] [KO:K04162]', 'HRH1 [HSA:3269] [KO:K04149]', 'ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]', 'DRD2 [HSA:1813] [KO:K04145]', 'DRD3 [HSA:1814] [KO:K04146]', 'DRD4 [HSA:1815] [KO:K04147]'], 'Pathway': ['hsa04080(146+147+148+1813+1814+1815+3269+3356+3357+3358+3362)  Neuroactive ligand-receptor interaction', 'hsa04726(3356+3357+3358+3362)  Serotonergic synapse', 'hsa04728(1813+1814+1815)  Dopaminergic synapse', 'Enzyme: CYP1A2 [HSA:1544]; CYP2D6 [HSA:1565]']}}, {'drug_concept_id': '745466', 'drug_name': 'valproate', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00304', 'D_number': 'D00304', 'Classes': [['DG01573', 'Calcium channel T type blocker'], ['DG02035', 'Fatty acid antiepileptic']], 'Target': ['ABAT [HSA:18] [KO:K13524]', 'SSADH [HSA:7915] [KO:K00139]', 'GAD [HSA:2571 2572] [KO:K01580]', 'CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]'], 'Pathway': ['hsa04020(8911+8912+8913)  Calcium signaling pathway', 'hsa04727(18+2571+2572)  GABAergic synapse']}}, {'drug_concept_id': '1101898', 'drug_name': 'leflunomide', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00749', 'D_number': 'D00749', 'Classes': [['DG01985', 'Disease modifying anti-rheumatic drug (DMARD)'], ['DG02913', 'CYP3A4 substrate'], ['DG01643', 'CYP2C9 inhibitor']], 'Target': ['DHODH [HSA:1723] [KO:K00254]'], 'Pathway': ['hsa00240(1723)  Pyrimidine metabolism', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['140586', '4272240'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10486965 {'drugs': [{'drug_concept_id': '1318011', 'drug_name': 'oxaliplatin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01790', 'D_number': 'D01790', 'Classes': [['DG01679', 'Platinum compound'], ['DG02854', 'SLC22A2 substrate']], 'Target': ['DNA', 'Transporter: SLC22A2 [HSA:6582], SLC22A1 [HSA:6580]'], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '4024567', '140586', '433595'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10497675 {'drugs': [{'drug_concept_id': '1318011', 'drug_name': 'oxaliplatin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01790', 'D_number': 'D01790', 'Classes': [['DG01679', 'Platinum compound'], ['DG02854', 'SLC22A2 substrate']], 'Target': ['DNA', 'Transporter: SLC22A2 [HSA:6582], SLC22A1 [HSA:6580]'], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '140586', '433595'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "KEGG_find_base = 'https://rest.kegg.jp/find/drug/'\n",
    "KEGG_get_base = 'https://rest.kegg.jp/get/'\n",
    "\n",
    "\n",
    "# function to generate the appropriate URLs for KEGG API queries\n",
    "# uses the find request to search a drug string, then determines the d-number of the drug for the get-url \n",
    "def KEGG_find_query(drug_string):\n",
    "    find_url = KEGG_find_base + drug_string\n",
    "    find_req = requests.get(find_url)\n",
    "    a = find_req.text.split(\"\\n\")\n",
    "    b = []\n",
    "    for l in a:\n",
    "        b.append(l.split(\"\\t\"))\n",
    "    b.pop()\n",
    "    # iterate through find entries to find INN names, extract the d number\n",
    "    # if multiple entries contain INN, store the first one\n",
    "    # if none, store the first\n",
    "    for found_entry in b:\n",
    "        if \"INN\" in found_entry[1]:\n",
    "            get_url = KEGG_get_base + found_entry[0]\n",
    "            x = found_entry[0].split(\":\")\n",
    "            d_number = x[1]\n",
    "            # put d number at end of get URL\n",
    "            return [find_url, get_url, d_number]\n",
    "    #print(\"find str:\", b[0])\n",
    "    temp = b[0][0].split(\":\")\n",
    "    d_number = temp[1]\n",
    "    return [find_url, KEGG_get_base + b[0][0], d_number]\n",
    "\n",
    "\n",
    "# send get request to Kegg and store drug targets, pathway, and class\n",
    "def KEGG_get_query(get_URL):\n",
    "    target = []\n",
    "    pathway = []\n",
    "    class_info = []\n",
    "    get_req = requests.get(get_URL)\n",
    "    klines = get_req.iter_lines()\n",
    "    # booleans to keep track of if a line stores info on pathway, class, or target\n",
    "    is_targ = 0\n",
    "    is_path = 0\n",
    "    is_class = 0\n",
    "    # iterate through get response\n",
    "    for line in klines:\n",
    "        dec = line.decode(\"utf-8\")\n",
    "        # line has class info\n",
    "        if dec.startswith(\"CLASS\"):\n",
    "            is_class = 1\n",
    "        # line does not have class info\n",
    "        if dec.startswith(\"REMARK\"):\n",
    "            is_class = 0\n",
    "        # line has target info\n",
    "        if dec.startswith(\"TARGET\"):\n",
    "            is_targ = 1\n",
    "        # line has pathway info, not target info\n",
    "        if dec[2:9]==\"PATHWAY\":\n",
    "            is_path = 1\n",
    "            is_targ = 0\n",
    "        # line no longer has path info\n",
    "        if dec.startswith(\"INTERACTION\"):\n",
    "            is_targ = 0\n",
    "            is_path = 0\n",
    "        # if the line corresponds to a field of interest, store it\n",
    "        if is_class == 1: \n",
    "            #print(dec)\n",
    "            # gets the name and dg-number of the most specific KEGG drug groups associated with the given d-number\n",
    "            class_info.append(dec[12:])\n",
    "        elif is_targ == 1: target.append(dec[12:])\n",
    "        elif is_path == 1: pathway.append(dec[12:])\n",
    "    # store most specific drug groups\n",
    "    class_list = []\n",
    "    for ind in range(len(class_info)):\n",
    "        #print(class_info[ind])\n",
    "        # add last class line by default\n",
    "        if ind == len(class_info) - 1:\n",
    "            split_line = class_info[ind].strip(\" \").split(\"  \")\n",
    "            class_list.append([split_line[0], split_line[1]])\n",
    "            break\n",
    "        if \" DG\" in class_info[ind]:\n",
    "            # not the most specific drug group; continue to next line\n",
    "            if \" DG\" in class_info[ind+1]: continue\n",
    "            else: \n",
    "                split_line = class_info[ind].strip(\" \").split(\"  \")\n",
    "                class_list.append([split_line[0], split_line[1]])\n",
    "    #print(\"\\n\", class_list)\n",
    "    return(target, pathway, class_list)\n",
    "\n",
    "#x = KEGG_get_query(\"https://rest.kegg.jp/get/dr:D02714\")\n",
    "#print(safetyreportid_list)\n",
    "for x in results_dict:\n",
    "    print(x, results_dict[x])\n",
    "    print(\"\\n\")\n",
    "          "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "catch 1!\n",
      "case id: 10085688\n",
      "https://rest.kegg.jp/find/drug/metformin / rosiglitazone Oral Tablet\n",
      "concept id: 40063306\n",
      "try2: https://rest.kegg.jp/find/drug/metformin rosiglitazone\n",
      "['https://rest.kegg.jp/find/drug/metformin rosiglitazone', 'https://rest.kegg.jp/get/dr:D10244', 'D10244']\n",
      "fix1:  https://rest.kegg.jp/find/drug/metformin rosiglitazone\n",
      "\n",
      "catch 1!\n",
      "case id: 10332098\n",
      "https://rest.kegg.jp/find/drug/calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution\n",
      "concept id: 40166942\n",
      "try2: https://rest.kegg.jp/find/drug/calcium /\n",
      "['https://rest.kegg.jp/find/drug/calcium /', 'https://rest.kegg.jp/get/dr:D00934', 'D00934']\n",
      "fix1:  https://rest.kegg.jp/find/drug/calcium /\n",
      "\n",
      "catch 1!\n",
      "case id: 10332098\n",
      "https://rest.kegg.jp/find/drug/calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution\n",
      "concept id: 40166942\n",
      "try2: https://rest.kegg.jp/find/drug/calcium /\n",
      "['https://rest.kegg.jp/find/drug/calcium /', 'https://rest.kegg.jp/get/dr:D00934', 'D00934']\n",
      "fix1:  https://rest.kegg.jp/find/drug/calcium /\n",
      "\n",
      "catch 1!\n",
      "case id: 10356294\n",
      "https://rest.kegg.jp/find/drug/metformin / rosiglitazone Oral Tablet\n",
      "concept id: 40063306\n",
      "try2: https://rest.kegg.jp/find/drug/metformin rosiglitazone\n",
      "['https://rest.kegg.jp/find/drug/metformin rosiglitazone', 'https://rest.kegg.jp/get/dr:D10244', 'D10244']\n",
      "fix1:  https://rest.kegg.jp/find/drug/metformin rosiglitazone\n",
      "\n",
      "catch 1!\n",
      "case id: 10357536\n",
      "https://rest.kegg.jp/find/drug/calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution\n",
      "concept id: 40166942\n",
      "try2: https://rest.kegg.jp/find/drug/calcium /\n",
      "['https://rest.kegg.jp/find/drug/calcium /', 'https://rest.kegg.jp/get/dr:D00934', 'D00934']\n",
      "fix1:  https://rest.kegg.jp/find/drug/calcium /\n",
      "\n",
      "catch 1!\n",
      "case id: 10357536\n",
      "https://rest.kegg.jp/find/drug/calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution\n",
      "concept id: 40166942\n",
      "try2: https://rest.kegg.jp/find/drug/calcium /\n",
      "['https://rest.kegg.jp/find/drug/calcium /', 'https://rest.kegg.jp/get/dr:D00934', 'D00934']\n",
      "fix1:  https://rest.kegg.jp/find/drug/calcium /\n",
      "\n",
      "catch 1!\n",
      "case id: 10393445\n",
      "https://rest.kegg.jp/find/drug/onabotulinumtoxinA\n",
      "concept id: 40165651\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 15, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 25, in get_KEGG_info\n",
      "    print(\"try2:\", KEGG_find_base + fix1[0] + \" \" + fix1[2])\n",
      "IndexError: list index out of range\n",
      "\n",
      "catch 2!\n",
      "error message: list index out of range\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 15, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 25, in get_KEGG_info\n",
      "    print(\"try2:\", KEGG_find_base + fix1[0] + \" \" + fix1[2])\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 36, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(fix2)\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "catch 3!\n",
      "error message: list index out of range\n",
      "No KEGG: onabotulinumtoxinA\n",
      "\n",
      "catch 1!\n",
      "case id: 10393445\n",
      "https://rest.kegg.jp/find/drug/cinnamon oil, leaf\n",
      "concept id: 42900311\n",
      "try2: https://rest.kegg.jp/find/drug/cinnamon leaf\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 15, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 26, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(fix1[0] + \" \" + fix1[2])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "catch 2!\n",
      "error message: list index out of range\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 15, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 26, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(fix1[0] + \" \" + fix1[2])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 36, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(fix2)\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "catch 3!\n",
      "error message: list index out of range\n",
      "No KEGG: cinnamon oil, leaf\n",
      "\n",
      "catch 1!\n",
      "case id: 10393445\n",
      "https://rest.kegg.jp/find/drug/tumeric oil\n",
      "concept id: 42900581\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 15, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 25, in get_KEGG_info\n",
      "    print(\"try2:\", KEGG_find_base + fix1[0] + \" \" + fix1[2])\n",
      "IndexError: list index out of range\n",
      "\n",
      "catch 2!\n",
      "error message: list index out of range\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 15, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 25, in get_KEGG_info\n",
      "    print(\"try2:\", KEGG_find_base + fix1[0] + \" \" + fix1[2])\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 36, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(fix2)\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "catch 3!\n",
      "error message: list index out of range\n",
      "No KEGG: tumeric oil\n",
      "\n",
      "catch 1!\n",
      "case id: 10393445\n",
      "https://rest.kegg.jp/find/drug/acetaminophen / aspirin / caffeine Oral Powder\n",
      "concept id: 40137949\n",
      "try2: https://rest.kegg.jp/find/drug/acetaminophen aspirin\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 15, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 26, in KEGG_find_query\n",
      "    temp = b[0][0].split(\":\")\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 26, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(fix1[0] + \" \" + fix1[2])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "catch 2!\n",
      "error message: list index out of range\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 15, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 26, in KEGG_find_query\n",
      "    temp = b[0][0].split(\":\")\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 26, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(fix1[0] + \" \" + fix1[2])\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 19, in KEGG_find_query\n",
      "    if \"INN\" in found_entry[1]:\n",
      "IndexError: list index out of range\n",
      "\n",
      "During handling of the above exception, another exception occurred:\n",
      "\n",
      "Traceback (most recent call last):\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1584019823.py\", line 36, in get_KEGG_info\n",
      "    kegg_find_results = KEGG_find_query(fix2)\n",
      "  File \"/var/folders/rk/6f1nd8k578nbxhsb86z46zch0000gp/T/ipykernel_916/1281411480.py\", line 26, in KEGG_find_query\n",
      "    temp = b[0][0].split(\":\")\n",
      "IndexError: list index out of range\n",
      "\n",
      "catch 3!\n",
      "error message: list index out of range\n",
      "No KEGG: acetaminophen / aspirin / caffeine Oral Powder\n"
     ]
    }
   ],
   "source": [
    "import traceback\n",
    "\n",
    "# update dictionary with info from KEGG API requests\n",
    "# copy for testing\n",
    "results_dict1 = results_dict.copy()\n",
    "def get_KEGG_info():\n",
    "    for reportID in results_dict1:\n",
    "        for drug in results_dict1[reportID]['drugs']:\n",
    "            if type(drug['KEGG']) == dict:\n",
    "                a = drug['KEGG'].copy()\n",
    "            else:\n",
    "                a = drug['KEGG']\n",
    "            # try fixes for common problems with find request\n",
    "            try:\n",
    "                kegg_find_results = KEGG_find_query(drug['drug_name'])\n",
    "            except:\n",
    "                print(\"\\ncatch 1!\")\n",
    "                print(\"case id:\", reportID)\n",
    "                print(KEGG_find_base + drug['drug_name'])\n",
    "                print(\"concept id:\", drug['drug_concept_id'])\n",
    "                # catching exception with drugs with hyphens\n",
    "                try:\n",
    "                    # try fix for mixture drugs\n",
    "                    fix1 = drug['drug_name'].split(\" \")\n",
    "                    print(\"try2:\", KEGG_find_base + fix1[0] + \" \" + fix1[2])\n",
    "                    kegg_find_results = KEGG_find_query(fix1[0] + \" \" + fix1[2])\n",
    "                    print(kegg_find_results)\n",
    "                    print(\"fix1: \", KEGG_find_base + fix1[0] + \" \" + fix1[2])\n",
    "                except Exception as e0:\n",
    "                    print(traceback.format_exc())\n",
    "                    # try fix for drugs with hyphens\n",
    "                    try:\n",
    "                        print(\"catch 2!\")\n",
    "                        print(\"error message:\", e0)\n",
    "                        fix2 = drug['drug_name'].replace(\"-\", \" \")\n",
    "                        kegg_find_results = KEGG_find_query(fix2)\n",
    "                        print(\"fixed 2:\", fix2)\n",
    "                    except Exception as e1:\n",
    "                        print(traceback.format_exc())\n",
    "                        print(\"catch 3!\")\n",
    "                        print(\"error message:\", e1)\n",
    "                        print(\"No KEGG:\", drug['drug_name'])\n",
    "                        a = \"No entry\"\n",
    "                        drug['KEGG'] = a\n",
    "                        continue    \n",
    "            kegg_get_results = KEGG_get_query(kegg_find_results[1])\n",
    "            if type(a) == dict:\n",
    "                a['get_URL'] = kegg_find_results[1]\n",
    "                a['D_number'] = kegg_find_results[2]\n",
    "                a['Target'] = kegg_get_results[0]\n",
    "                a['Pathway'] = kegg_get_results[1]\n",
    "                a['Classes'] = kegg_get_results[2]\n",
    "                drug['KEGG'] = a\n",
    "\n",
    "get_KEGG_info()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO: \n",
    "# Figure out what to do when there are multiple lines with INN\n",
    "# Figure out what to do with safetyreportids with no corresponding AEOLUS entries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10020013 {'drugs': [{'drug_concept_id': '1112921', 'drug_name': 'ipratropium', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D02212', 'D_number': 'D02212', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist']], 'Target': ['CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]'], 'Pathway': ['hsa04024(1128+1129)  cAMP signaling pathway', 'hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction', 'hsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse']}}, {'drug_concept_id': '1149380', 'drug_name': 'fluticasone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D06315', 'D_number': 'D06315', 'Classes': [['DG02068', 'Glucocorticoid'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3C1 (GR) [HSA:2908] [KO:K05771]'], 'Pathway': ['hsa04080(2908)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1154343', 'drug_name': 'albuterol', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08124', 'D_number': 'D08124', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction']}}], 'reactions_SNOMED': ['\\\\N', '75909', '256722', '373347', '4024567', '140586', '4029966', '255848', '76241'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10025924 {'drugs': [{'drug_concept_id': '1315942', 'drug_name': 'docetaxel', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07866', 'D_number': 'D07866', 'Classes': [['DG02913', 'CYP3A4 substrate']], 'Target': ['TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]'], 'Pathway': ['hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1344905', 'drug_name': 'carboplatin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01363', 'D_number': 'D01363', 'Classes': [['DG01679', 'Platinum compound']], 'Target': ['DNA'], 'Pathway': []}}, {'drug_concept_id': '1314577', 'drug_name': 'nebivolol', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D05127', 'D_number': 'D05127', 'Classes': [['DG03231', 'Antihypertensive'], ['DG01644', 'CYP2D6 substrate']], 'Target': ['ADRB1 [HSA:153] [KO:K04141]'], 'Pathway': ['hsa04080(153)  Neuroactive ligand-receptor interaction', 'hsa04261(153)  Adrenergic signaling in cardiomyocytes', 'Enzyme: CYP2D6 [HSA:1565]']}}, {'drug_concept_id': '1506270', 'drug_name': 'methylprednisolone', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00407', 'D_number': 'D00407', 'Classes': [['DG02068', 'Glucocorticoid'], ['DG03243', 'Atopic dermatitis agent'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3C1 (GR) [HSA:2908] [KO:K05771]'], 'Pathway': ['hsa04080(2908)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1501700', 'drug_name': 'levothyroxine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D11113', 'D_number': 'D11113', 'Classes': [['DG01608', 'Thyroid hormone replenisher']], 'Target': ['NR1A (THR) [HSA:7067 7068] [KO:K05547 K08362]'], 'Pathway': ['hsa04080(7067+7068)  Neuroactive ligand-receptor interaction', 'hsa04919(7067+7068)  Thyroid hormone signaling pathway']}}], 'reactions_SNOMED': ['4086587', '137193', '140586', '4090424'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10085688 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '745466', 'drug_name': 'valproate', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00304', 'D_number': 'D00304', 'Classes': [['DG01573', 'Calcium channel T type blocker'], ['DG02035', 'Fatty acid antiepileptic']], 'Target': ['ABAT [HSA:18] [KO:K13524]', 'SSADH [HSA:7915] [KO:K00139]', 'GAD [HSA:2571 2572] [KO:K01580]', 'CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]'], 'Pathway': ['hsa04020(8911+8912+8913)  Calcium signaling pathway', 'hsa04727(18+2571+2572)  GABAergic synapse']}}, {'drug_concept_id': '40063306', 'drug_name': 'metformin / rosiglitazone Oral Tablet', 'role_cod': 'C', 'KEGG': 'No entry'}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10151788 {'drugs': [{'drug_concept_id': '1151789', 'drug_name': 'etanercept', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00742', 'D_number': 'D00742', 'Classes': [['DG01936', 'TNF inhibitor']], 'Target': ['TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]', 'LTA (TNFB, TNFSF1) [HSA:4049] [KO:K05468]'], 'Pathway': ['hsa04010(7124)  MAPK signaling pathway', 'hsa04060(4049+7124)  Cytokine-cytokine receptor interaction', 'hsa04064(4049+7124)  NF-kappa B signaling pathway', 'hsa04210(7124)  Apoptosis', 'hsa04350(7124)  TGF-beta signaling pathway', 'hsa04380(7124)  Osteoclast differentiation', 'hsa04612(7124)  Antigen processing and presentation', 'hsa04920(7124)  Adipocytokine signaling pathway', 'hsa05323(7124)  Rheumatoid arthritis']}}], 'reactions_SNOMED': ['133280', '437113', '196523', '4223938', '375527', '140586', '442752', '31967', '4079185', '441408'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10153358 {'drugs': [{'drug_concept_id': '722424', 'drug_name': 'interferon beta-1a', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D10483', 'D_number': 'D10483', 'Classes': [['DG01752', 'Interferone']], 'Target': ['IFNAR1 [HSA:3454] [KO:K05130]', 'IFNAR2 [HSA:3455] [KO:K05131]'], 'Pathway': ['hsa04060(3454+3455)  Cytokine-cytokine receptor interaction', 'hsa04620(3454+3455)  Toll-like receptor signaling pathway', 'hsa04630(3454+3455)  JAK-STAT signaling pathway', 'hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity']}}, {'drug_concept_id': '722424', 'drug_name': 'interferon beta-1a', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D10483', 'D_number': 'D10483', 'Classes': [['DG01752', 'Interferone']], 'Target': ['IFNAR1 [HSA:3454] [KO:K05130]', 'IFNAR2 [HSA:3455] [KO:K05131]'], 'Pathway': ['hsa04060(3454+3455)  Cytokine-cytokine receptor interaction', 'hsa04620(3454+3455)  Toll-like receptor signaling pathway', 'hsa04630(3454+3455)  JAK-STAT signaling pathway', 'hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity']}}], 'reactions_SNOMED': ['\\\\N', '4071366', '317009', '73819', '442165', '140586', '4042563', '4275882', '4319159', '74052', '4272240', '4224178', '31967', '4320791', '4152347', '441408'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10184459 {'drugs': [{'drug_concept_id': '735843', 'drug_name': 'natalizumab', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D06886', 'D_number': 'D06886', 'Classes': [], 'Target': ['ITGA4 (CD49D) [HSA:3676] [KO:K06483]'], 'Pathway': ['hsa04512(3676)  ECM-receptor interaction', 'hsa04670(3676)  Leukocyte transendothelial migration']}}], 'reactions_SNOMED': ['\\\\N', '377091', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10185517 {'drugs': [{'drug_concept_id': '42900584', 'drug_name': 'teriflunomide', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D10172', 'D_number': 'D10172', 'Classes': [], 'Target': ['DHODH [HSA:1723] [KO:K00254]'], 'Pathway': ['hsa00240(1723)  Pyrimidine metabolism']}}], 'reactions_SNOMED': ['440213', '4239038', '435796', '436093', '441830', '201340', '140586', '140821', '4187218', '137967'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10197970 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '435242', '140586', '434610', '316866', '4208994', '4245042', '4050941', '441553', '378165', '444419', '444070', '317376'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10222368 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '436093', '4340781', '140586', '317002', '193355', '197320', '4291649'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10227575 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '436093', '4340781', '140586', '317002', '193355', '4212484', '197320', '4291649'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10232590 {'drugs': [{'drug_concept_id': '904453', 'drug_name': 'esomeprazole', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07917', 'D_number': 'D07917', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa00190(495+496)  Oxidative phosphorylation', 'hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '904453', 'drug_name': 'esomeprazole', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07917', 'D_number': 'D07917', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa00190(495+496)  Oxidative phosphorylation', 'hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '19039926', 'drug_name': 'dexlansoprazole', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08903', 'D_number': 'D08903', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate'], ['DG01933', 'CYP2C19 inhibitor']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1367500', 'drug_name': 'losartan', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08146', 'D_number': 'D08146', 'Classes': [['DG01495', 'Angiotensin II receptor antagonist'], ['DG01642', 'CYP2C9 substrate']], 'Target': ['AGTR1 [HSA:185] [KO:K04166]'], 'Pathway': ['hsa04080(185)  Neuroactive ligand-receptor interaction', 'hsa04261(185)  Adrenergic signaling in cardiomyocytes', 'hsa04270(185)  Vascular smooth muscle contraction', 'hsa04614(185)  Renin-angiotensin system', 'Enzyme: CYP2C9 [HSA:1559]']}}, {'drug_concept_id': '1112807', 'drug_name': 'aspirin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D03385', 'D_number': 'D03385', 'Classes': [['DG01712', 'Antiplatelet agent'], ['DG01909', 'Anti-inflammatory drug, salicylic acid derivatives']], 'Target': [], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '437113', '437744', '4272240', '31967', '441408'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10239703 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '436093', '4340781', '140586', '317002', '193355', '197320', '4291649'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10240593 {'drugs': [{'drug_concept_id': '19100985', 'drug_name': 'panitumumab', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D05350', 'D_number': 'D05350', 'Classes': [['DG03162', 'EGFR inhibitor']], 'Target': ['EGFR [HSA:1956] [KO:K04361]'], 'Pathway': ['hsa04010(1956)  MAPK signaling pathway', 'hsa04012(1956)  ErbB signaling pathway', 'hsa05200(1956)  Pathways in cancer']}}], 'reactions_SNOMED': ['\\\\N', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10258737 {'drugs': [{'drug_concept_id': '916005', 'drug_name': 'solifenacin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01269', 'D_number': 'D01269', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '916005', 'drug_name': 'solifenacin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01269', 'D_number': 'D01269', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['140586', '192450'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10260965 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '4175340', '436093', '4340781', '192671', '140586', '317002', '193355', '197320'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10277071 {'drugs': [{'drug_concept_id': '1351115', 'drug_name': 'ubidecarenone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01065', 'D_number': 'D01065', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '19011773', 'drug_name': 'ascorbic acid', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00018', 'D_number': 'D00018', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '19008339', 'drug_name': 'vitamin A', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00100', 'D_number': 'D00100', 'Classes': [['DG01603', 'Vitamin K'], ['DG03232', 'Osteoporosis agent']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '19009405', 'drug_name': 'vitamin D', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00100', 'D_number': 'D00100', 'Classes': [['DG01603', 'Vitamin K'], ['DG03232', 'Osteoporosis agent']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '916005', 'drug_name': 'solifenacin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01269', 'D_number': 'D01269', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '916005', 'drug_name': 'solifenacin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01269', 'D_number': 'D01269', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1360332', 'drug_name': 'glucosamine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D04334', 'D_number': 'D04334', 'Classes': [], 'Target': [], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '381273', '75860', '435796', '4052648', '4327654', '195562', '140586', '4154784', '442752', '192450'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10277585 {'drugs': [{'drug_concept_id': '757688', 'drug_name': 'aripiprazole', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01164', 'D_number': 'D01164', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'DRD3 [HSA:1814] [KO:K04146]', 'HTR1A [HSA:3350] [KO:K04153]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+1814+3350+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3350+3356)  Serotonergic synapse', 'hsa04728(1813+1814)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]']}}], 'reactions_SNOMED': ['140586', '255848'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10291524 {'drugs': [{'drug_concept_id': '1133201', 'drug_name': 'buprenorphine', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07132', 'D_number': 'D07132', 'Classes': [['DG01586', 'Opioid receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['OPRK1 [HSA:4986] [KO:K04214]', 'OPRM1 [HSA:4988] [KO:K04215]'], 'Pathway': ['hsa04080(4986+4988)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '4318383', '4319311', '4223938', '437744', '138565', '31967'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10292628 {'drugs': [{'drug_concept_id': '1133201', 'drug_name': 'buprenorphine', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07132', 'D_number': 'D07132', 'Classes': [['DG01586', 'Opioid receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['OPRK1 [HSA:4986] [KO:K04214]', 'OPRM1 [HSA:4988] [KO:K04215]'], 'Pathway': ['hsa04080(4986+4988)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10301206 {'drugs': [{'drug_concept_id': '1548195', 'drug_name': 'estradiol', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00105', 'D_number': 'D00105', 'Classes': [['DG01584', 'Estrogen receptor agonist'], ['DG03232', 'Osteoporosis agent'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3A (ESR) [HSA:2099 2100] [KO:K08550 K08551]'], 'Pathway': ['hsa04915(2099+2100)  Estrogen signaling pathway', 'hsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1154029', 'drug_name': 'fentanyl', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00320', 'D_number': 'D00320', 'Classes': [['DG01563', 'mu-Opioid receptor agonist'], ['DG01984', 'Opioid analgesics'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['OPRM1 [HSA:4988] [KO:K04215]'], 'Pathway': ['hsa04080(4988)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '381316', '4276665', '4162724', '140586', '138565'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10301801 {'drugs': [{'drug_concept_id': '42900505', 'drug_name': 'linaclotide', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D06612', 'D_number': 'D06612', 'Classes': [['DG01770', 'Laxative']], 'Target': ['GUCY2C [HSA:2984] [KO:K12320]'], 'Pathway': []}}], 'reactions_SNOMED': ['4223938', '439926', '140586', '4113666'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10314922 {'drugs': [{'drug_concept_id': '904453', 'drug_name': 'esomeprazole', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07917', 'D_number': 'D07917', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa00190(495+496)  Oxidative phosphorylation', 'hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['4223938', '140586', '31967', '436817'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10332098 {'drugs': [{'drug_concept_id': '40166942', 'drug_name': 'calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution', 'role_cod': 'PS', 'KEGG': 'No entry'}, {'drug_concept_id': '40166942', 'drug_name': 'calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution', 'role_cod': 'SS', 'KEGG': 'No entry'}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10340496 {'drugs': [{'drug_concept_id': '791967', 'drug_name': 'lorazepam', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00365', 'D_number': 'D00365', 'Classes': [['DG03199', 'Antiepileptic agent'], ['DG03187', 'UGT2B15 substrate']], 'Target': ['GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]'], 'Pathway': ['hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse', 'Enzyme: UGT2B7 [HSA:7364], UGT2B15 [HSA:7366]']}}, {'drug_concept_id': '1149196', 'drug_name': 'cetirizine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07402', 'D_number': 'D07402', 'Classes': [['DG01482', 'Histamine receptor H1 antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['HRH1 [HSA:3269] [KO:K04149]'], 'Pathway': ['hsa04080(3269)  Neuroactive ligand-receptor interaction', 'hsa04750(3269)  Inflammatory mediator regulation of TRP channels', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '703547', 'drug_name': 'trazodone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08626', 'D_number': 'D08626', 'Classes': [['DG03056', 'Serotonin antagonist and reuptake inhibitor (SARI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['SLC6A4 (HTT) [HSA:6532] [KO:K05037]', 'HTR2 [HSA:3356 3357 3358] [KO:K04157]'], 'Pathway': ['hsa04080(3356+3357+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(3356+3357+3358+6532)  Serotonergic synapse', 'Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]']}}, {'drug_concept_id': '1506270', 'drug_name': 'methylprednisolone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00407', 'D_number': 'D00407', 'Classes': [['DG02068', 'Glucocorticoid'], ['DG03243', 'Atopic dermatitis agent'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3C1 (GR) [HSA:2908] [KO:K05771]'], 'Pathway': ['hsa04080(2908)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1322184', 'drug_name': 'clopidogrel', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07729', 'D_number': 'D07729', 'Classes': [['DG01808', 'Thienopyridine'], ['DG02913', 'CYP3A4 substrate'], ['DG01641', 'CYP2C8 inhibitor']], 'Target': ['P2RY12 [HSA:64805] [KO:K04298]', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2B6 [HSA:1555]'], 'Pathway': []}}, {'drug_concept_id': '1334456', 'drug_name': 'ramipril', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00421', 'D_number': 'D00421', 'Classes': [['DG01501', 'Angiotensin-converting enzyme inhibitor']], 'Target': ['ACE (CD143) [HSA:1636] [KO:K01283]'], 'Pathway': ['hsa04614(1636)  Renin-angiotensin system']}}, {'drug_concept_id': '956874', 'drug_name': 'furosemide', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00331', 'D_number': 'D00331', 'Classes': [['DG01747', 'Furosemide type diuretic'], ['DG02860', 'SLC22A8 substrate']], 'Target': ['SLC12A1 (NKCC2) [HSA:6557] [KO:K14425]', 'SLC12A2 (NKCC1) [HSA:6558] [KO:K10951]', 'Transporter: SLC22A6 [HSA:9356], SLC22A8 [HSA:9376], ABCC4 [HSA:10257]'], 'Pathway': []}}], 'reactions_SNOMED': ['140586', '4232311', '135360'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10345902 {'drugs': [{'drug_concept_id': '1151789', 'drug_name': 'etanercept', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00742', 'D_number': 'D00742', 'Classes': [['DG01936', 'TNF inhibitor']], 'Target': ['TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]', 'LTA (TNFB, TNFSF1) [HSA:4049] [KO:K05468]'], 'Pathway': ['hsa04010(7124)  MAPK signaling pathway', 'hsa04060(4049+7124)  Cytokine-cytokine receptor interaction', 'hsa04064(4049+7124)  NF-kappa B signaling pathway', 'hsa04210(7124)  Apoptosis', 'hsa04350(7124)  TGF-beta signaling pathway', 'hsa04380(7124)  Osteoclast differentiation', 'hsa04612(7124)  Antigen processing and presentation', 'hsa04920(7124)  Adipocytokine signaling pathway', 'hsa05323(7124)  Rheumatoid arthritis']}}], 'reactions_SNOMED': ['436583', '375415', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10352353 {'drugs': [{'drug_concept_id': '1501700', 'drug_name': 'levothyroxine', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D11113', 'D_number': 'D11113', 'Classes': [['DG01608', 'Thyroid hormone replenisher']], 'Target': ['NR1A (THR) [HSA:7067 7068] [KO:K05547 K08362]'], 'Pathway': ['hsa04080(7067+7068)  Neuroactive ligand-receptor interaction', 'hsa04919(7067+7068)  Thyroid hormone signaling pathway']}}, {'drug_concept_id': '1501700', 'drug_name': 'levothyroxine', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D11113', 'D_number': 'D11113', 'Classes': [['DG01608', 'Thyroid hormone replenisher']], 'Target': ['NR1A (THR) [HSA:7067 7068] [KO:K05547 K08362]'], 'Pathway': ['hsa04080(7067+7068)  Neuroactive ligand-receptor interaction', 'hsa04919(7067+7068)  Thyroid hormone signaling pathway']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '\\\\N', '4086587', '434490', '4276665', '4162724', '437744', '436962', '4154927', '4056883', '140214', '4152347', '437985', '4079185'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10354933 {'drugs': [{'drug_concept_id': '1557272', 'drug_name': 'alendronate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00939', 'D_number': 'D00939', 'Classes': [['DG01600', 'Bisphosphonate']], 'Target': ['FDPS [HSA:2224] [KO:K00787]'], 'Pathway': ['hsa00900(2224)  Terpenoid backbone biosynthesis']}}], 'reactions_SNOMED': ['140586', '4161682'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10356294 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '40063306', 'drug_name': 'metformin / rosiglitazone Oral Tablet', 'role_cod': 'C', 'KEGG': 'No entry'}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10357536 {'drugs': [{'drug_concept_id': '40166942', 'drug_name': 'calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution', 'role_cod': 'SS', 'KEGG': 'No entry'}, {'drug_concept_id': '40166942', 'drug_name': 'calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution', 'role_cod': 'PS', 'KEGG': 'No entry'}], 'reactions_SNOMED': ['313217', '140586', '318459'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10358718 {'drugs': [{'drug_concept_id': '1106776', 'drug_name': 'tiotropium', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01929', 'D_number': 'D01929', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist']], 'Target': ['CHRM3 [HSA:1131] [KO:K04131]'], 'Pathway': ['hsa04020(1131)  Calcium signaling pathway', 'hsa04080(1131)  Neuroactive ligand-receptor interaction', 'hsa04725(1131)  Cholinergic synapse']}}], 'reactions_SNOMED': ['4024567', '140586', '4161682', '444070'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10363868 {'drugs': [{'drug_concept_id': '1322184', 'drug_name': 'clopidogrel', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07729', 'D_number': 'D07729', 'Classes': [['DG01808', 'Thienopyridine'], ['DG02913', 'CYP3A4 substrate'], ['DG01641', 'CYP2C8 inhibitor']], 'Target': ['P2RY12 [HSA:64805] [KO:K04298]', 'Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2B6 [HSA:1555]'], 'Pathway': []}}, {'drug_concept_id': '956874', 'drug_name': 'furosemide', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00331', 'D_number': 'D00331', 'Classes': [['DG01747', 'Furosemide type diuretic'], ['DG02860', 'SLC22A8 substrate']], 'Target': ['SLC12A1 (NKCC2) [HSA:6557] [KO:K14425]', 'SLC12A2 (NKCC1) [HSA:6558] [KO:K10951]', 'Transporter: SLC22A6 [HSA:9356], SLC22A8 [HSA:9376], ABCC4 [HSA:10257]'], 'Pathway': []}}, {'drug_concept_id': '1334456', 'drug_name': 'ramipril', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00421', 'D_number': 'D00421', 'Classes': [['DG01501', 'Angiotensin-converting enzyme inhibitor']], 'Target': ['ACE (CD143) [HSA:1636] [KO:K01283]'], 'Pathway': ['hsa04614(1636)  Renin-angiotensin system']}}, {'drug_concept_id': '703547', 'drug_name': 'trazodone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08626', 'D_number': 'D08626', 'Classes': [['DG03056', 'Serotonin antagonist and reuptake inhibitor (SARI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['SLC6A4 (HTT) [HSA:6532] [KO:K05037]', 'HTR2 [HSA:3356 3357 3358] [KO:K04157]'], 'Pathway': ['hsa04080(3356+3357+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(3356+3357+3358+6532)  Serotonergic synapse', 'Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]']}}], 'reactions_SNOMED': ['140586', '4232311', '135360'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10363961 {'drugs': [{'drug_concept_id': '44785094', 'drug_name': 'sofosbuvir', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D10366', 'D_number': 'D10366', 'Classes': [['DG02000', 'HCV NS5B polymerase inhibitor'], ['DG01913', 'ABCG2 substrate']], 'Target': ['HCV NS5B polymerase [KO:K22472]'], 'Pathway': ['ko03230(K22472)  Viral genome structure', 'ko03240(K22472)  Viral replication', 'ko05160(K22472)  Hepatitis C', 'Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]']}}, {'drug_concept_id': '1762711', 'drug_name': 'ribavirin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00423', 'D_number': 'D00423', 'Classes': [['DG02000', 'HCV NS5B polymerase inhibitor']], 'Target': ['HCV NS5B polymerase [KO:K22472]'], 'Pathway': ['ko03230(K22472)  Viral genome structure', 'ko03240(K22472)  Viral replication', 'ko05160(K22472)  Hepatitis C']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '437113', '435796', '196523', '436667', '4147189', '439926', '4162724', '375527', '437744', '138565', '4318719', '372448', '140821', '138525', '437663', '377575', '432941', '439977', '435928'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10364041 {'drugs': [{'drug_concept_id': '1151789', 'drug_name': 'etanercept', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00742', 'D_number': 'D00742', 'Classes': [['DG01936', 'TNF inhibitor']], 'Target': ['TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]', 'LTA (TNFB, TNFSF1) [HSA:4049] [KO:K05468]'], 'Pathway': ['hsa04010(7124)  MAPK signaling pathway', 'hsa04060(4049+7124)  Cytokine-cytokine receptor interaction', 'hsa04064(4049+7124)  NF-kappa B signaling pathway', 'hsa04210(7124)  Apoptosis', 'hsa04350(7124)  TGF-beta signaling pathway', 'hsa04380(7124)  Osteoclast differentiation', 'hsa04612(7124)  Antigen processing and presentation', 'hsa04920(7124)  Adipocytokine signaling pathway', 'hsa05323(7124)  Rheumatoid arthritis']}}], 'reactions_SNOMED': ['375527', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10370403 {'drugs': [{'drug_concept_id': '1196677', 'drug_name': 'formoterol', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07463', 'D_number': 'D07463', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction']}}, {'drug_concept_id': '1154343', 'drug_name': 'albuterol', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08124', 'D_number': 'D08124', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction']}}, {'drug_concept_id': '1112921', 'drug_name': 'ipratropium', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D02212', 'D_number': 'D02212', 'Classes': [['DG01491', 'Muscarinic cholinergic receptor antagonist']], 'Target': ['CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]'], 'Pathway': ['hsa04024(1128+1129)  cAMP signaling pathway', 'hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction', 'hsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse']}}], 'reactions_SNOMED': ['4024567', '437744', '4161682', '444070'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10371125 {'drugs': [{'drug_concept_id': '920293', 'drug_name': 'nitrofurantoin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00439', 'D_number': 'D00439', 'Classes': [['DG01552', 'Hydantoin type nitrofuran']], 'Target': [], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '434490', '140586', '441408'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10387545 {'drugs': [{'drug_concept_id': '1549786', 'drug_name': 'ethinyl estradiol', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00554', 'D_number': 'D00554', 'Classes': [['DG01584', 'Estrogen receptor agonist'], ['DG02913', 'CYP3A4 substrate'], ['DG01522', 'CYP3A4 inhibitor']], 'Target': ['NR3A1 (ESR1) [HSA:2099] [KO:K08550]'], 'Pathway': ['hsa04915(2099)  Estrogen signaling pathway', 'hsa05200(2099)  Pathways in cancer', 'hsa05224(2099)  Breast cancer', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '441542', '4090870', '4133004', '375527', '140586', '4319450', '440417'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10392544 {'drugs': [{'drug_concept_id': '991382', 'drug_name': 'amiloride', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07447', 'D_number': 'D07447', 'Classes': [['DG01885', 'Potassium-sparing diuretic']], 'Target': ['SCNN1 [HSA:6337 6338 6340] [KO:K04824 K04825 K04827]'], 'Pathway': ['hsa04960(6337+6338+6340)  Aldosterone-regulated sodium reabsorption']}}, {'drug_concept_id': '725131', 'drug_name': 'mirtazapine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00563', 'D_number': 'D00563', 'Classes': [['DG01460', 'alpha2-Adrenergic receptor antagonist'], ['DG03077', 'Noradrenergic and specific serotonergic antidepressant (NaSSA)'], ['DG01489', '5-HT3-receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['HTR2 [HSA:3356 3357 3358] [KO:K04157]', 'HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]', 'ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]'], 'Pathway': ['hsa04080(150+151+152+3356+3357+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(170572+200909+285242+3356+3357+3358+3359+9177)  Serotonergic synapse', 'Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1178663', 'drug_name': 'indomethacin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00141', 'D_number': 'D00141', 'Classes': [['DG01899', 'Anti-inflammatory drug, indoleacetic acid derivatives']], 'Target': ['PTGS1 (COX1) [HSA:5742] [KO:K00509]', 'PTGS2 (COX2) [HSA:5743] [KO:K11987]'], 'Pathway': ['hsa00590(5742+5743)  Arachidonic acid metabolism']}}, {'drug_concept_id': '1332418', 'drug_name': 'amlodipine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07450', 'D_number': 'D07450', 'Classes': [['DG01928', 'Dihydropyridine calcium channel blocker'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04260(775+776+778+779)  Cardiac muscle contraction', 'hsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes', 'hsa04270(775+776+778+779)  Vascular smooth muscle contraction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '19095002', 'drug_name': 'chlorprothixene', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00790', 'D_number': 'D00790', 'Classes': [], 'Target': ['DRD1 [HSA:1812] [KO:K04144]', 'DRD2 [HSA:1813] [KO:K04145]'], 'Pathway': ['hsa04080(1812+1813)  Neuroactive ligand-receptor interaction', 'hsa04728(1812+1813)  Dopaminergic synapse']}}, {'drug_concept_id': '800878', 'drug_name': 'clozapine', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00283', 'D_number': 'D00283', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['HTR2A [HSA:3356] [KO:K04157]', 'HTR2C [HSA:3358] [KO:K04157]', 'HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]', 'ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]', 'DRD4 [HSA:1815] [KO:K04147]'], 'Pathway': ['hsa04080(150+151+152+1815+3356+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(170572+200909+285242+3356+3358+3359+9177)  Serotonergic synapse', 'hsa04728(1815)  Dopaminergic synapse', 'Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1503297', 'drug_name': 'metformin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D04966', 'D_number': 'D04966', 'Classes': [['DG01684', 'Biguanide antidiabetic']], 'Target': ['AMPK (PRKAA) [HSA:5562 5563] [KO:K07198]'], 'Pathway': ['hsa04152(5562+5563)  AMPK signaling pathway', 'hsa04910(5562+5563)  Insulin signaling pathway', 'hsa04920(5562+5563)  Adipocytokine signaling pathway']}}, {'drug_concept_id': '800878', 'drug_name': 'clozapine', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00283', 'D_number': 'D00283', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['HTR2A [HSA:3356] [KO:K04157]', 'HTR2C [HSA:3358] [KO:K04157]', 'HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]', 'ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]', 'DRD4 [HSA:1815] [KO:K04147]'], 'Pathway': ['hsa04080(150+151+152+1815+3356+3358)  Neuroactive ligand-receptor interaction', 'hsa04726(170572+200909+285242+3356+3358+3359+9177)  Serotonergic synapse', 'hsa04728(1815)  Dopaminergic synapse', 'Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '924566', 'drug_name': 'tamsulosin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08560', 'D_number': 'D08560', 'Classes': [['DG01457', 'alpha1-Adrenergic receptor antagonist']], 'Target': ['ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]'], 'Pathway': ['hsa04022(146+147+148)  cGMP-PKG signaling pathway', 'hsa04080(146+147+148)  Neuroactive ligand-receptor interaction', 'hsa04270(146+147+148)  Vascular smooth muscle contraction']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '256722', '140586', '379802', '437985', '4028970'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10393445 {'drugs': [{'drug_concept_id': '42709324', 'drug_name': 'vitamin D3', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00188', 'D_number': 'D00188', 'Classes': [['DG01607', 'Vitamin D derivatives']], 'Target': ['NR1I1 (VDR) [HSA:7421] [KO:K08539]'], 'Pathway': ['hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption', 'hsa04978(7421)  Mineral absorption']}}, {'drug_concept_id': '19111620', 'drug_name': 'folic acid', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00070', 'D_number': 'D00070', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '1125315', 'drug_name': 'acetaminophen', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00217', 'D_number': 'D00217', 'Classes': [['DG01981', 'Anilide derivative, anti-inflammatory']], 'Target': ['PTGS1 (COX1) [HSA:5742] [KO:K00509]', 'PTGS2 (COX2) [HSA:5743] [KO:K11987]'], 'Pathway': ['hsa00590(5742+5743)  Arachidonic acid metabolism']}}, {'drug_concept_id': '40165651', 'drug_name': 'onabotulinumtoxinA', 'role_cod': 'C', 'KEGG': 'No entry'}, {'drug_concept_id': '19062817', 'drug_name': 'riboflavin', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00050', 'D_number': 'D00050', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '778711', 'drug_name': 'cyclobenzaprine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07758', 'D_number': 'D07758', 'Classes': [['DG01974', 'Centrally acting muscle relaxant']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '42900311', 'drug_name': 'cinnamon oil, leaf', 'role_cod': 'C', 'KEGG': 'No entry'}, {'drug_concept_id': '19008339', 'drug_name': 'vitamin A', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00100', 'D_number': 'D00100', 'Classes': [['DG01603', 'Vitamin K'], ['DG03232', 'Osteoporosis agent']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '42900581', 'drug_name': 'tumeric oil', 'role_cod': 'C', 'KEGG': 'No entry'}, {'drug_concept_id': '1308216', 'drug_name': 'lisinopril', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08131', 'D_number': 'D08131', 'Classes': [['DG01501', 'Angiotensin-converting enzyme inhibitor']], 'Target': ['ACE (CD143) [HSA:1636] [KO:K01283]'], 'Pathway': ['hsa04614(1636)  Renin-angiotensin system']}}, {'drug_concept_id': '1149380', 'drug_name': 'fluticasone', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D06315', 'D_number': 'D06315', 'Classes': [['DG02068', 'Glucocorticoid'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['NR3C1 (GR) [HSA:2908] [KO:K05771]'], 'Pathway': ['hsa04080(2908)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1734104', 'drug_name': 'azithromycin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07486', 'D_number': 'D07486', 'Classes': [['DG01875', '15-Membered ring macrolide antibiotic'], ['DG01665', 'ABCB1 substrate'], ['DG01622', 'ABCB1 inhibitor']], 'Target': ['50S ribosomal subunit'], 'Pathway': ['ko03010(K01980)  Ribosome', 'Transporter: ABCB1 [HSA:5243]']}}, {'drug_concept_id': '40137949', 'drug_name': 'acetaminophen / aspirin / caffeine Oral Powder', 'role_cod': 'C', 'KEGG': 'No entry'}, {'drug_concept_id': '752061', 'drug_name': 'prochlorperazine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00493', 'D_number': 'D00493', 'Classes': [['DG01905', 'Phenothiazine antipsychotics']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]'], 'Pathway': ['hsa04080(1813)  Neuroactive ligand-receptor interaction', 'hsa04728(1813)  Dopaminergic synapse']}}, {'drug_concept_id': '1112807', 'drug_name': 'aspirin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D03385', 'D_number': 'D03385', 'Classes': [['DG01712', 'Antiplatelet agent'], ['DG01909', 'Anti-inflammatory drug, salicylic acid derivatives']], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '1539403', 'drug_name': 'simvastatin', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00434', 'D_number': 'D00434', 'Classes': [['DG01660', 'HMG-CoA reductase inhibitor'], ['DG02913', 'CYP3A4 substrate'], ['DG02856', 'SLCO1B1 substrate']], 'Target': ['HMGCR [HSA:3156] [KO:K00021]'], 'Pathway': ['hsa00900(3156)  Terpenoid backbone biosynthesis', 'Enzyme: CYP3A4 [HSA:1576]', 'Transporter: SLCO1B1 [HSA:10599]']}}, {'drug_concept_id': '705103', 'drug_name': 'lamotrigine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00354', 'D_number': 'D00354', 'Classes': [['DG03199', 'Antiepileptic agent'], ['DG03182', 'UGT1A4 substrate']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: UGT1A4 [HSA:54657]']}}, {'drug_concept_id': '1137529', 'drug_name': 'salmeterol', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D05792', 'D_number': 'D05792', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '1154343', 'drug_name': 'albuterol', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08124', 'D_number': 'D08124', 'Classes': [['DG01452', 'beta2-Adrenergic receptor agonist']], 'Target': ['ADRB2 [HSA:154] [KO:K04142]'], 'Pathway': ['hsa04020(154)  Calcium signaling pathway', 'hsa04024(154)  cAMP signaling pathway', 'hsa04080(154)  Neuroactive ligand-receptor interaction']}}, {'drug_concept_id': '19011773', 'drug_name': 'ascorbic acid', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00018', 'D_number': 'D00018', 'Classes': [], 'Target': [], 'Pathway': []}}, {'drug_concept_id': '710062', 'drug_name': 'amitriptyline', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07448', 'D_number': 'D07448', 'Classes': [['DG01728', 'Tricyclic antidepressant'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['SLC6A4 (HTT) [HSA:6532] [KO:K05037]', 'SLC6A2 (NAT1) [HSA:6530] [KO:K05035]'], 'Pathway': ['hsa04721(6530+6532)  Synaptic vesicle cycle', 'hsa04726(6532)  Serotonergic synapse', 'Enzyme: CYP2D6 [HSA:1565]; CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]']}}, {'drug_concept_id': '743670', 'drug_name': 'venlafaxine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07793', 'D_number': 'D07793', 'Classes': [['DG01658', 'Serotonin and norepinephrine reuptake inhibitor (SNRI)'], ['DG02924', 'UGT substrate']], 'Target': ['SLC6A4 (HTT) [HSA:6532] [KO:K05037]', 'SLC6A2 (NAT1) [HSA:6530] [KO:K05035]'], 'Pathway': ['hsa04721(6530+6532)  Synaptic vesicle cycle', 'hsa04726(6532)  Serotonergic synapse', 'Enzyme: CYP3A4 [HSA:1576], UGT [KO:K00699]']}}, {'drug_concept_id': '911735', 'drug_name': 'rabeprazole', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D08463', 'D_number': 'D08463', 'Classes': [['DG01646', 'Proton pump inhibitor (PPI)'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['ATP4 [HSA:495 496] [KO:K01542 K01543]'], 'Pathway': ['hsa04966(495+496)  Collecting duct acid secretion', 'hsa04971(495+496)  Gastric acid secretion', 'Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '433128', '317002', '4086587', '256451', '77670', '195588', '4033051', '196523', '4223938', '197913', '4024567', '4302537', '437744', '192964', '4028389', '318736', '31967', '4329041', '255848', '441408', '435928'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10403686 {'drugs': [{'drug_concept_id': '1636780', 'drug_name': 'testosterone', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00408', 'D_number': 'D00408', 'Classes': [['DG02006', 'Testosterone']], 'Target': ['NR3C4 (AR) [HSA:367] [KO:K08557]'], 'Pathway': ['hsa04114(367)  Oocyte meiosis', 'hsa05200(367)  Pathways in cancer']}}], 'reactions_SNOMED': ['\\\\N', '4319311', '439926', '140586', '138565'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10409393 {'drugs': [{'drug_concept_id': '713196', 'drug_name': 'interferon beta-1b', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00746', 'D_number': 'D00746', 'Classes': [['DG01752', 'Interferone']], 'Target': ['IFNAR1 [HSA:3454] [KO:K05130]', 'IFNAR2 [HSA:3455] [KO:K05131]'], 'Pathway': ['hsa04060(3454+3455)  Cytokine-cytokine receptor interaction', 'hsa04620(3454+3455)  Toll-like receptor signaling pathway', 'hsa04630(3454+3455)  JAK-STAT signaling pathway', 'hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity']}}, {'drug_concept_id': '705944', 'drug_name': 'methylphenidate', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D04999', 'D_number': 'D04999', 'Classes': [], 'Target': ['SLC6A3 (DAT1) [HSA:6531] [KO:K05036]', 'SLC6A2 (NAT1) [HSA:6530] [KO:K05035]'], 'Pathway': ['hsa04721(6530+6531)  Synaptic vesicle cycle', 'hsa04728(6531)  Dopaminergic synapse']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '441207', '438557', '437643', '437744', '4316207', '79908'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10417536 {'drugs': [{'drug_concept_id': '43526424', 'drug_name': 'dimethyl fumarate', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D03846', 'D_number': 'D03846', 'Classes': [], 'Target': ['KEAP1 [HSA:9817] [KO:K10456]'], 'Pathway': []}}, {'drug_concept_id': '43526424', 'drug_name': 'dimethyl fumarate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D03846', 'D_number': 'D03846', 'Classes': [], 'Target': ['KEAP1 [HSA:9817] [KO:K10456]'], 'Pathway': []}}], 'reactions_SNOMED': ['437113', '318566', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10422942 {'drugs': [{'drug_concept_id': '723013', 'drug_name': 'diazepam', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00293', 'D_number': 'D00293', 'Classes': [['DG03199', 'Antiepileptic agent'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]'], 'Pathway': ['hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse', 'Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '798874', 'drug_name': 'clonazepam', 'role_cod': 'SS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00280', 'D_number': 'D00280', 'Classes': [['DG02036', 'Benzodiazepine derivative, antiepileptic']], 'Target': ['GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]'], 'Pathway': ['hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse']}}], 'reactions_SNOMED': ['4099943', '441260', '140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10435129 {'drugs': [{'drug_concept_id': '735979', 'drug_name': 'risperidone', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00426', 'D_number': 'D00426', 'Classes': [['DG03064', 'Atypical antipsychotic'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['DRD2 [HSA:1813] [KO:K04145]', 'HTR2A [HSA:3356] [KO:K04157]'], 'Pathway': ['hsa04080(1813+3356)  Neuroactive ligand-receptor interaction', 'hsa04726(3356)  Serotonergic synapse', 'hsa04728(1813)  Dopaminergic synapse', 'Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '740275', 'drug_name': 'carbamazepine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00252', 'D_number': 'D00252', 'Classes': [['DG02034', 'Carboxamide antiepileptic'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer'], ['DG01893', 'ABCB1 inducer']], 'Target': ['SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]'], 'Pathway': ['hsa04728(6323)  Dopaminergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}, {'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['\\\\N', '\\\\N', '\\\\N', '\\\\N', '436093', '4340781', '444070', '140586', '317002', '193355', '4212484', '197320', '4291649'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10444519 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10456262 {'drugs': [{'drug_concept_id': '742267', 'drug_name': 'topiramate', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00537', 'D_number': 'D00537', 'Classes': [['DG01496', 'Calcium channel L type blocker'], ['DG01569', 'AMPA receptor antagonist'], ['DG02913', 'CYP3A4 substrate']], 'Target': ['GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]', 'GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]', 'CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]', 'SCN1A [HSA:6323] [KO:K04833]', 'SCN2A [HSA:6326] [KO:K04834]', 'SCN3A [HSA:6328] [KO:K04836]', 'SCN4A [HSA:6329] [KO:K04837]', 'SCN5A [HSA:6331] [KO:K04838]', 'SCN8A [HSA:6334] [KO:K04840]', 'SCN9A [HSA:6335] [KO:K04841]', 'SCN10A [HSA:6336] [KO:K04842]', 'SCN11A [HSA:11280] [KO:K04843]', 'GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]', 'CA2 [HSA:760] [KO:K18245]', 'CA4 [HSA:762] [KO:K18246]'], 'Pathway': ['hsa04020(775+776+778+779)  Calcium signaling pathway', 'hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+2890+2891+2892+2893+2897+2898+2899+2900+2901+55879)  Neuroactive ligand-receptor interaction', 'hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+775+776)  Glutamatergic synapse', 'hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+775+776+778+779)  GABAergic synapse', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['140586'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10456952 {'drugs': [{'drug_concept_id': '1321636', 'drug_name': 'bosentan', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D07538', 'D_number': 'D07538', 'Classes': [['DG01502', 'Endothelin receptor antagonist'], ['DG02913', 'CYP3A4 substrate'], ['DG01635', 'CYP3A4 inducer']], 'Target': ['EDNR [HSA:1909 1910] [KO:K04197 K04198]'], 'Pathway': ['hsa04080(1909+1910)  Neuroactive ligand-receptor interaction', 'hsa04270(1909)  Vascular smooth muscle contraction', 'Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['4024567', '437744'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10473904 {'drugs': [{'drug_concept_id': '1318011', 'drug_name': 'oxaliplatin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01790', 'D_number': 'D01790', 'Classes': [['DG01679', 'Platinum compound'], ['DG02854', 'SLC22A2 substrate']], 'Target': ['DNA', 'Transporter: SLC22A2 [HSA:6582], SLC22A1 [HSA:6580]'], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '4024567', '140586', '433595'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10486791 {'drugs': [{'drug_concept_id': '785788', 'drug_name': 'olanzapine', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00454', 'D_number': 'D00454', 'Classes': [['DG01457', 'alpha1-Adrenergic receptor antagonist'], ['DG03064', 'Atypical antipsychotic'], ['DG01482', 'Histamine receptor H1 antagonist'], ['DG01644', 'CYP2D6 substrate']], 'Target': ['HTR2 [HSA:3356 3357 3358] [KO:K04157]', 'HTR6 [HSA:3362] [KO:K04162]', 'HRH1 [HSA:3269] [KO:K04149]', 'ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]', 'DRD2 [HSA:1813] [KO:K04145]', 'DRD3 [HSA:1814] [KO:K04146]', 'DRD4 [HSA:1815] [KO:K04147]'], 'Pathway': ['hsa04080(146+147+148+1813+1814+1815+3269+3356+3357+3358+3362)  Neuroactive ligand-receptor interaction', 'hsa04726(3356+3357+3358+3362)  Serotonergic synapse', 'hsa04728(1813+1814+1815)  Dopaminergic synapse', 'Enzyme: CYP1A2 [HSA:1544]; CYP2D6 [HSA:1565]']}}, {'drug_concept_id': '745466', 'drug_name': 'valproate', 'role_cod': 'C', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00304', 'D_number': 'D00304', 'Classes': [['DG01573', 'Calcium channel T type blocker'], ['DG02035', 'Fatty acid antiepileptic']], 'Target': ['ABAT [HSA:18] [KO:K13524]', 'SSADH [HSA:7915] [KO:K00139]', 'GAD [HSA:2571 2572] [KO:K01580]', 'CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]'], 'Pathway': ['hsa04020(8911+8912+8913)  Calcium signaling pathway', 'hsa04727(18+2571+2572)  GABAergic synapse']}}, {'drug_concept_id': '1101898', 'drug_name': 'leflunomide', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D00749', 'D_number': 'D00749', 'Classes': [['DG01985', 'Disease modifying anti-rheumatic drug (DMARD)'], ['DG02913', 'CYP3A4 substrate'], ['DG01643', 'CYP2C9 inhibitor']], 'Target': ['DHODH [HSA:1723] [KO:K00254]'], 'Pathway': ['hsa00240(1723)  Pyrimidine metabolism', 'Enzyme: CYP3A4 [HSA:1576]']}}], 'reactions_SNOMED': ['140586', '4272240'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10486965 {'drugs': [{'drug_concept_id': '1318011', 'drug_name': 'oxaliplatin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01790', 'D_number': 'D01790', 'Classes': [['DG01679', 'Platinum compound'], ['DG02854', 'SLC22A2 substrate']], 'Target': ['DNA', 'Transporter: SLC22A2 [HSA:6582], SLC22A1 [HSA:6580]'], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '4024567', '140586', '433595'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n",
      "10497675 {'drugs': [{'drug_concept_id': '1318011', 'drug_name': 'oxaliplatin', 'role_cod': 'PS', 'KEGG': {'get_URL': 'https://rest.kegg.jp/get/dr:D01790', 'D_number': 'D01790', 'Classes': [['DG01679', 'Platinum compound'], ['DG02854', 'SLC22A2 substrate']], 'Target': ['DNA', 'Transporter: SLC22A2 [HSA:6582], SLC22A1 [HSA:6580]'], 'Pathway': []}}], 'reactions_SNOMED': ['\\\\N', '140586', '433595'], 'reactions_MedDRA:': []}\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "#print(safetyreportid_list)\n",
    "for x in results_dict1:\n",
    "    print(x, results_dict1[x])\n",
    "    print(\"\\n\")\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.9.12 ('base')",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "25bed791a1aed4bb13420da74a485fcfdcafbc9ecdc61a40322d51322f2b5a38"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
